study_ID trait case_description control_description PMID ES00033 body mass index (BMI) 24630777 ES00034 body mass index (BMI) 24630777 ES00035 body mass index (BMI) 28002404 ES00036 body mass index (BMI) BMI 28095459 ES00037 childhood obesity BMI above the age- and sex-specific 97th percentile according to the Spanish BMI reference charts healthy subjects with the BMI below the 97th percentile of the same reference charts 28614626 ES00038 body mass index (BMI) BMI 28947923 ES00039 waist circumference (WC) WC 28947923 ES00041 body mass index (BMI) BMI 25935004 ES00043 waist circumference (WC) WC 25935004 ES00045 body mass index (BMI) BMI 25935004 ES00046 waist circumference (WC) WC 25935004 ES00047 aging age 20219944 ES00048 systolic blood pressure systolic blood pressure 29198723 ES00049 aging age 20219945 ES00052 aging age 22532803 ES00053 aging age 23061750 ES00054 aging age 23177740 ES00055 aging age 24138928 ES00056 aging age 24163245 ES00057 aging age 24287154 ES00058 aging age 24490752 ES00059 aging age 27029739 ES00060 aging age 28255110 ES00061 aging age 29172065 ES00062 aggressive behavior aggression score 26508088 ES00063 air pollution (PM2.5) PM2.5 concentration 26731791 ES00064 maternal NO2 exposure during pregnancy mean concentrations of NO2 during pregnancy 27448387 ES00065 air pollution (PM2.5) PM2.5 concentration 27903268 ES00066 one-year moving averages of PM2.5 species (Fe) one-year moving averages of Fe 27982729 ES00067 one-year moving averages of PM2.5 species (Ni) one-year moving averages of Ni 27982729 ES00068 one-year moving averages of PM2.5 species (V) one-year moving averages of V 27982729 ES00069 long-term air pollution exposure levels (NO2) NO2 concentration 28843141 ES00070 long-term air pollution exposure levels (NOx) NOx concentration 28843141 ES00072 long-term air pollution exposure levels (PM2.5) PM2.5 concentration 28843141 ES00074 long-term air pollution exposure levels (PM2.5 absorbance) PM2.5 absorbance (PM2.5abs) determined by measurement of light reflectance 28843141 ES00075 alcohol consumption total consumption of beer, wine and spirits 27843151 ES00076 alcohol consumption total consumption of beer, wine and spirits 27843151 ES00077 alcohol consumption total consumption of beer, wine and spirits 27843151 ES00078 alcohol consumption alcohol use every week for the past 26 weeks no use in the past 6 months 22514556 ES00079 alcohol consumption use of alcohol in between 9 and 25 weeks in the past 6 months and alcohol use in every week in the past 6 months no use in the past 6 months 22514556 ES00080 smoking smoking status 21457905 ES00081 smoking current smokers never smokers 22492999 ES00082 smoking highest pack-years quartile lowest pack-years quartile 22492999 ES00083 smoking cessation highest time quit quartile lowest time quit quartile 22492999 ES00084 smoking smoking status 23070629 ES00085 smoking smoking status 23070629 ES00086 smoking smoking status 23175441 ES00087 smoking smoking status 23657504 ES00088 smoking current smokers never smokers 23691101 ES00089 smoking former smokers never smokers 23691101 ES00093 smoking smoking status 24334605 ES00094 smoking smokers non-smokers 24485148 ES00095 smoking smokers non-smokers 24559495 ES00096 smoking smoking status 24704585 ES00097 smoking smoking status 25424692 ES00098 smoking current smokers never smokers 25517428 ES00100 smoking current smokers never smokers 25556184 ES00101 smoking former smokers never smokers 25556184 ES00102 smoking smoking status 25663950 ES00103 gender 25663950 ES00104 aging age 25663950 ES00106 smoking smokers non-smokers 26043106 ES00107 smoking pack-years 26181258 ES00109 smoking current smokers former smokers 26646902 ES00110 smoking smoking status 26756918 ES00111 smoking smoking status 26825526 ES00112 smoking serum cotinine (ng/ml) 26826776 ES00113 smoking smoking status 26829059 ES00114 smoking smoking status 26864933 ES00115 smoking smoking status 26913089 ES00116 smoking pack-years 27602958 ES00117 smoking current smokers never smokers 27651444 ES00118 smoking former smokers never smokers 27651444 ES00119 smoking current smokers never smokers 27688819 ES00120 smoking smokers non-smokers 28416970 ES00121 smoking smokers non-smokers 28503748 ES00122 smoking smokers non-smokers 28950428 ES00123 smoking smoking status 29047347 ES00124 smoking smoking status 22427682 ES00125 child abuse maltreated children removed from their parents due to abuse demographically matched control children 23332324 ES00126 exercise after a six months exercise before six months exercise 23825961 ES00127 exercise leg with training during 3 months leg without training during 3 months 25484259 ES00128 exercise after four weeks (thrice weekly) of sprint interval training before four weeks (thrice weekly) of sprint interval training 25539938 ES00129 exercise after 3 months of exercise training before 3 months of exercise training 25864559 ES00130 exercise after 8 weeks of resistance exercise training before 8 weeks of resistance exercise training 27155847 ES00131 weight loss change in percent body weight over a six-month period 29049890 ES00132 child abuse maltreated children healthy nontraumatized children 24655651 ES00136 anxiety patients with anxiety disorders healthy controls 28540928 ES00137 tea consumption tea consumption (cups/month) 28535255 ES00138 birth weight normal birthweight low birthweight 26750116 ES00139 wellbeing satisfaction with life 26619905 ES00140 amygdala:hippocampal (AH) volume AH volume 28480579 ES00141 atypical antipsychotic-induced insulin resistance HOMA-IR (indicating an insulin-resistant state) 27542345 ES00142 derivatives of reactive oxygen metabolites (D-ROM) in plasma D-ROM levels 26173806 ES00145 maternal famine exposure famine exposure during specific 10-week gestation periods non-exposure control 25944819 ES00146 folic acid and vitamin B12 supplementation Folic acid and vitamin B12 Placebo 26568774 ES00147 serum folate serum folate levels 26568774 ES00148 serum vitamin B12 serum vitamin B12 levels 26568774 ES00149 plasma homocysteine (Hcy) levels plasma homocysteine levels 26568774 ES00150 fruit consumption fruit consumption during the past year 28708104 ES00151 juice consumption juice consumption during the past year 28708104 ES00152 intracytoplasmic sperm injection conceived through ICSI conceived spontaneously 28575352 ES00154 maternal smoking maternal plasma cotinine measured during pregnancy 22851337 ES00157 acute mania acute mania healthy controls 26147665 ES00158 season of birth season of birth 26973132 ES00159 allergic rhinitis allergic rhinitis healthy controls 28755526 ES00161 ascending aortic dissection (AD) AD patients healthy controls 28444195 ES00162 bicuspid aortic valve (BAV) BAV hAD patients 28444195 ES00164 diastolic blood pressure diastolic blood pressure 29198723 ES00165 air pollution (PM2.5) PM2.5 concentration 26731791 ES00166 air pollution (PM2.5) PM2.5 concentration 26731791 ES00167 long-term air pollution exposure levels (PM10) PM10 concentration 28843141 ES00169 fetal brain development gestational age 27468947 ES00174 maternal smoking maternal smoking status in pregnancy 27040690 ES00179 high saturated fatty acids diet high saturated fatty acids diet high polyunsaturated fatty acids diet 28275132 ES00180 preterm birth spontaneous preterm birth full-term babies 28165855 ES00181 preterm birth preterm samples term samples 28428831 ES00182 preterm birth preterm samples term samples 28428831 ES00183 preterm birth preterm samples term samples 28428831 ES00184 preterm birth preterm samples term samples 28428831 ES00185 fetal alcohol spectrum disorder (FASD) FASD healthy controls 26178076 ES00186 in utero arsenic exposure in utero arsenic levels 23757598 ES00187 prenatal arsenic exposure arsenic in maternal drinking water collected ?16 weeks gestational age 24525453 ES00189 in utero arsenic exposure concentration of arsenic metabolites in spot urine samples 24965135 ES00190 in utero arsenic exposure concentration of arsenic metabolites in spot urine samples 24965135 ES00191 prenatal arsenic exposure iAs levels in drinking water (DW-iAs; mg/l) and the levels of total maternal urinary arsenic (U-tAs; mg/l) 25304211 ES00192 prenatal mercury (Hg) exposure prenatal mercury exposure 25923418 ES00193 prenatal co-exposure to mercury (Hg) and arsenic (As) prenatal co-exposure to mercury (Hg) and arsenic (As) 25923418 ES00194 in utero arsenic exposure arsenic level in drinking water 26646901 ES00195 in utero arsenic exposure arsenic level in drinking water 26646901 ES00196 in utero arsenic exposure arsenic level in drinking water 26646901 ES00198 sperm motility sperm motility 27529490 ES00199 sperm viability sperm viability 27529490 ES00200 substance-use risk substance use (tobacco, alcohol and cannabis use) 27922636 ES00202 1,6-hexamethylene diisocyanate exposure average creatinine adjusted urine HDA levels 25445006 ES00203 1,6-hexamethylene diisocyanate exposure 1,6-hexamethylene diisocyanate exposure 25445006 ES00204 arsenic exposure high-exposed low-exposed 24368509 ES00205 arsenic-induced skin lesion developed arsenic-induced skin lesions in a ten year period healthy controls 24677489 ES00206 arsenic exposure urinary total arsenic concentration 25325195 ES00207 arsenic exposure blood arsenic concentration 25325195 ES00208 arsenic exposure sum of arsenicmetabolites in urine 28242323 ES00210 maternal cadmium exposure cadmium concentrations in mothers’ blood 23644563 ES00211 maternal cadmium exposure cadmium concentrations in mothers’ blood 23644563 ES00212 maternal cadmium exposure cadmium concentrations in mothers’ blood 23644563 ES00214 potasium dichromate exposure after exposed to potassium dichromate for 24 h before exposed to potassium dichromate for 24 h 26433257 ES00215 lead chromate exposure after exposed to potassium lead chromate for 24 h before exposed to potassium lead chromate for 24 h 26433257 ES00216 maternal alcohol consumption sustained maternal alcohol consumption during pregnancy unexposed 29172695 ES00217 maternal alcohol consumption binge drinking during pregnancy unexposed 29172695 ES00218 maternal alcohol consumption maternal alcohol consumption before pregnancy unexposed 29172695 ES00219 maternal alcohol consumption maternal alcohol consumption in the first trimester unexposed 29172695 ES00220 maternal alcohol consumption maternal alcohol consumption in the second or third trimester unexposed 29172695 ES00221 asthma asthmatic adults nonasthmatic adults 27942592 ES00223 atherosclerosis atherosclerosis patients healthy controls 28698603 ES00224 attention-deficit/hyperactivity disorder (ADHD) trajectories of ADHD symptoms 27217153 ES00227 autism spectrum disorders (ASD) ASD patients healthy controls 27404287 ES00229 bipolar disorder and major depressive disorder carriers of the linked haplotye (LH) married in controls 26798408 ES00230 bipolar disorder and major depressive disorder affected individuals carrying the linked haplotype (ALH) married in controls 26798408 ES00231 bipolar disorder and major depressive disorder individuals who subsequently developed BD or MDD those who remained well 27440233 ES00233 confined placental trisomy 16 mosaicism 3rd trimester CPM16 placental samples gestational age matched controls 24462402 ES00234 aortic valve stenosis (AVS) newborns who had aortic valve stenosis gestational-age matched controls 27152866 ES00235 perimembranous ventricular septal defect children with perimembranous ventricular septal defects healthy controls 28140654 ES00236 smoking smoking status 26015811 ES00240 Crohn's disease (CD) CD patients healthy controls 25144570 ES00241 Crohn's disease (CD) CD patients healthy controls 27279921 ES00242 dilated cardiomyopathy (DCM) left ventricle right ventricle 27417303 ES00245 endometriosis endometriosis normal endometrium 28125717 ES00248 fetal alcohol spectrum disorder (FASD) FASD healthy controls 27358653 ES00249 gestational diabetes mellitus GDM control pregnancies 28360945 ES00250 Helicobacter pylori eradication after successful H.pylori eradication before successful H.pylori eradication 27206798 ES00252 HIV infection HIV-infected HIV-uninfected 27672717 ES00253 HIV infection HIV-positive HIV-negative 27922854 ES00254 human herpesvirus 6B infection HHV-6B-infected HHV-6B-uninfected 28298607 ES00255 food allergy children with IgE-mediated food allergy diagnosed at 12-months 12 non-allergic controls 24762976 ES00256 infertility normospermic infertile patients normospermic fertile men 25753583 ES00257 infertility infertile patients fertile donors 27692602 ES00259 multiple sclerosis multiple sclerosis-affected brains control brains 24270187 ES00260 multiple sclerosis patients with relapsing-remitting MS healthy controls 24336351 ES00261 multiple sclerosis relapsing-remitting MS healthy controls 28729889 ES00262 myasthenia gravis Myasthenia gravis healthy controls 28549776 ES00263 anencephaly anencephaly healthy controls 26889207 ES00264 nonobstructive azoospermia (NOA) nonobstructive azoospermia normal spermatogenesis 25064398 ES00267 Parkinson's disease (PD) PD patients brothers or twins without PD 27709425 ES00270 respiratory allergies (RA) RA healthy controls 26999364 ES00271 respiratory allergies (RA) RA healthy controls 26999364 ES00272 rheumatoid arthritis (RA) RA healthy controls 25147922 ES00273 rheumatoid arthritis (RA) RA healthy controls 25147922 ES00274 rheumatoid arthritis (RA) early RA patients healthy controls 26556652 ES00275 rheumatoid arthritis (RA) early RA patients healthy controls 26556652 ES00276 rheumatoid arthritis (RA) RA patients healthy controls 27585642 ES00277 response to disease-modifying antirheumatic drugs in early rheumatoid arthritis responders non-responders 27885849 ES00278 plasma homocysteine (Hcy) levels plasma homocysteine levels 23774737 ES00281 severe acute malnutrition adult survivors of kwashiorkor adult survivors of marasmus 28330812 ES00284 kidney disease diabetic kidney disease individuals without renal disease 25850930 ES00285 type 1 diabetes (T1D) TID twins without T1D 26782299 ES00287 type 2 diabetes (T2D) T2D non-diabetic donors 22293752 ES00288 type 2 diabetes (T2D) T2D healthy controls 23251491 ES00289 type 2 diabetes (T2D) T2D healthy controls 23251491 ES00290 type 2 diabetes (T2D) T2D healthy controls 24603685 ES00291 type 2 diabetes (T2D) T2D twins without T2D 24812430 ES00293 type 2 diabetes (T2D) incident type 2 diabetes healthy controls 26095709 ES00294 type 2 diabetes (T2D) T2D healthy controls 26101197 ES00295 type 2 diabetes (T2D) T2D nondiabetic controls 26418287 ES00296 type 2 diabetes (T2D) T2D healthy controls 26433941 ES00297 type 2 diabetes (T2D) T2D healthy controls 26643952 ES00298 type 2 diabetes (T2D) T2D healthy controls 26823690 ES00299 body mass index (BMI) BMI 26823690 ES00300 obesity Obese Non-Diabetic Non-Obese Controls 26977391 ES00303 type 2 diabetes (T2D) T2D healthy controls 29164275 ES00305 B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 other pre-B ALL types 23722552 ES00306 B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 other pre-B ALL types 26237075 ES00307 B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) other pre-B ALL types 26237075 ES00308 Hyperdiploid B Acute Lymphoblastic Leukemia Hyperdiploid B Acute Lymphoblastic Leukemia other pre-B ALL types 26237075 ES00309 B Acute Lymphoblastic Leukemia with dic(9;20)(p11;q13) B Acute Lymphoblastic Leukemia with dic(9;20)(p11;q13) other pre-B ALL types 26237075 ES00311 pediatric acute lymphoblastic leukemia pediatric acute lymphoblastic leukemia healthy controls 27643535 ES00352 smoking cessation after smoking cessation before smoking cessation 25556184 ES00355 chronic obstructive pulmonary disease (COPD) COPD non-smokers 28416970 ES00356 chronic obstructive pulmonary disease (COPD) COPD smokers 28416970 ES00357 smoking cessation longitudinal time since quitting 29047347 ES00363 glioma survival time of patients 29535343 ES00365 gestational diabetes mellitus infants born to women with GDM infants born to women with normal pregnancy 29596946 ES00367 cerebral palsy cerebral palsy healthy controls 29484035 ES00370 homocysteine levels plasma homocysteine levels 28990796 ES00374 maternal famine exposure famine exposure during any of the gestation periods non-exposure control 25944819 ES00389 lung carcinoma survival time of patients 29667778 ES00413 maternal pre-pregnancy body mass index (BMI) maternal BMI 29016858 ES00414 sexual functioning Female Sexual Function Index 28964710 ES00415 sexual desire sexual desire 28964710 ES00416 lubrication lubrication 28964710 ES00417 satisfaction satisfaction 28964710 ES00420 physical activity time spent on moderate-to-vigorous physical activity 29582722 ES00422 prostate cancer primary PCa adjacent samples 28938548 ES00428 maternal phthalate exposure concentrations of three metabolites of di-(2-ethylhexyl) phthalate (DEHP) (ng/mL) 29367177 ES00432 atherosclerosis atherosclerotic human aorta healthy controls 25091541 ES00434 preeclampsia preeclampsia-affected pregnancies healthy pregnancies 26968548 ES00435 hepatocellular carcinoma (HCC) HCC tumor adjacent non-tumor tissues 23208076 ES00437 maternal smoking maternal plasmatic cotinine levels ranged from 10.70-115.40 ng/ml maternal plasmatic cotinine levels ranged from 0-0.59 ng/ml 25623364 ES00438 aging age 28693600 ES00439 post-traumatic stress disorder (PTSD) PTSD healthy controls 28654093 ES00440 major depression disorder MDD healthy controls 28654093 ES00441 aging age 28637423 ES00442 orofacial cleft cleft palate 28603561 ES00443 smoking current smokers never smokers 28576685 ES00448 childhood asthma children with asthma healthy controls 29496485 ES00449 smoking smoking status 29456763 ES00450 oral squamous cell carcinoma (OSCC) oral cancer matched normal 28890207 ES00452 Helicobacter pylori eradication after successful H.pylori eradication before successful H.pylori eradication 27206798 ES00453 multiple sclerosis relapsing remitting MS patients healthy blood donors 26550040 ES00469 birth weight birth weight (g) 29064478 ES00472 maternal smoking mother smoking at trial entry non-smokers 29064478 ES00475 serum IL-10 levels serum IL-10 levels 28637423 ES00476 serum TNF levels serum TNF levels 28637423 ES00477 serum IL6 levels serum IL6 levels 28637423 ES00478 serum IL8 levels serum IL8 levels 28637423 ES00479 aging age 28603561 ES00485 Kabuki syndrome (KS) patients with pathogenic mutations in KMT2D healthy controls 28933623 ES00486 gender girls boys 26553366 ES00496 preeclampsia early-onset preeclampsia (EOPET) age-matched controls from pre-term births 23770704 ES00497 fetal intolerance of labor 29235940 ES00498 schizophrenia patients with schizophrenia non-psychiatric controls 26619358 ES00502 type 2 diabetes (T2D) Obese Type 2 Diabetic Obese Non-Diabetic 26977391 ES00503 blood HbA1c levels blood HbA1c levels 26643952 ES00505 cow's milk allergy cow’s milk allergy healthy controls 27148440 ES00506 in utero arsenic exposure concentration of arsenic metabolites in spot urine samples 24965135 ES00508 total thiol levels (TTL) in plasma TTL levels 26173806 ES00509 smoking pack-years 23691101 ES00510 smoking current smokers never smokers 23691101 ES00511 smoking current smokers never smokers 23691101 ES00515 lung function lung function (forced expiratory volume the first second, FEV1) 29299071 ES00516 lung function lung function (forced vital capacity, FVC) 29299071 ES00517 lung function lung function (FEV1/FVC) 29299071 ES00519 gastric cancer (GC) early onset elderly onset 29342273 ES00520 high-risk non-muscle invasive bladder cancer (HR-NMIBC) primary initial diagnosis HR-NMIBC 29343995 ES00523 fetal alcohol spectrum disorder (FASD) fetal alcohol spectrum disorder healthy controls 29344313 ES00525 response to influenza vaccination responders non-responders 29360511 ES00526 response to influenza vaccination responders in older (age ? 50) non-responders 29360511 ES00527 polycystic ovary syndrome (PCOS) polycystic ovary syndrome healthy controls 29326659 ES00528 response to influenza vaccination responders in younger (age < 50) non-responders 29360511 ES00533 maternal cadmium exposure placental Cd concentrations 29373860 ES00534 impaired fasting glucose (IFG) normoglycemic Old Order Amish (OOA) individuals who later developed Impaired Fasting Glucose (IFG) normoglycemic control 29376147 ES00535 aging age 29383109 ES00536 air pollution (NO2) NO2 exposure 29410382 ES00537 interstitial cystitis/bladder pain syndrome (IC/BPS) IC/BPS patients healthy controls 29363787 ES00538 muscle hypertrophy 7 weeks of resistance exercise baseline 29382913 ES00539 muscle hypertrophy return of muscle mass to baseline baseline 29382913 ES00540 muscle hypertrophy later hypertrophy (reloading) baseline 29382913 ES00541 smoking smokers non-smokers 29315717 ES00542 mortality mortality 29419728 ES00543 narcolepsy narcolepsy healthy controls 29425374 ES00544 gastric cancer (GC) gastric cancer patients healthy individuals with gastric atrophy 29427040 ES00545 atherosclerotic plaque atheromatous plaque lesions corresponding plaque-free intima 29436575 ES00546 systemic lupus erythematosus (SLE) patients with SLE healthy controls 29437559 ES00547 Claes-Jensen syndrome Claes-Jensen syndrome healthy controls 29456765 ES00548 occupational pesticide exposure occupational pesticide exposure 29459480 ES00549 occupational pesticide exposure occupational pesticide exposure in never-smokers 29459480 ES00550 occupational pesticide exposure occupational pesticide exposure in current-smokers 29459480 ES00551 occupational pesticide exposure occupational pesticide exposure in subjects with airway obstruction 29459480 ES00552 gestational diabetes mellitus gestational diabetes-exposed healthy controls 29461653 ES00553 type 2 diabetes (T2D) diabetic individuals with obesity non-diabetic individuals with obesity 29466957 ES00554 type 2 diabetes (T2D) diabetic individuals with obesity non-diabetic individuals with obesity 29466957 ES00555 type 2 diabetes (T2D) diabetic individuals with obesity non-diabetic individuals with obesity 29466957 ES00557 obesity BMI percentile ??95% BMI percentile ??50% 29312471 ES00558 gestational diabetes mellitus gestational diabetes mellitus (GDM) healthy controls 29470513 ES00559 gestational diabetes mellitus gestational diabetes mellitus (GDM) healthy controls 29470513 ES00560 gestational diabetes mellitus gestational diabetes mellitus (GDM) healthy controls 29470513 ES00561 preterm birth spontaneous extremely preterm births indicated deliveries from extremely preterm births 29513726 ES00562 bone mineral density (BMD) bone mineral density in postmenopausal women 29514638 ES00563 phlegm-dampness constitution phlegm-dampness constitution balanced constitution 29518789 ES00564 maternal Hepatitis B virus (HBV) infection HBsAg-positive during pregnancy healthy controls 29526602 ES00565 folic acid supplement low folate intake high folate intake 29540272 ES00566 bladder cancer pre-diagnostic bladder cancer cases healthy controls 29540343 ES00567 maternal perfluoroalkyl substance exposure perfluorooctane sulfonate (PFOS) levels in maternal serum 29544137 ES00568 prenatal perfluoroalkyl substance exposure perfluorooctanoic acid (PFOA) levels in maternal serum 29544137 ES00569 folic acid supplement during pregnancy low and high dose folic acid supplement placebo 29546377 ES00570 folic acid supplement during pregnancy high dose folic acid supplement placebo 29546377 ES00571 folic acid supplement during pregnancy low dose folic acid supplement placebo 29546377 ES00572 t(1;11) translocation t(1;11) carriers healthy controls 29555928 ES00573 Helicobacter pylori infection current Helicobacter pylori infection Helicobacter pylori negative 29574700 ES00574 Helicobacter pylori infection past Helicobacter pylori infection Helicobacter pylori negative 29574700 ES00576 autism spectrum disorders (ASD) ASD patients healthy controls 29587883 ES00577 maternal PM10 exposure maternal PM10 exposure 29597345 ES00578 down syndrome down syndrome patients healthy controls 29601581 ES00579 circulating TNF-? concentration circulating TNF-? levels 29617535 ES00580 maternal smoking sustained-smokers never-smokers 29618728 ES00581 maternal smoking stopped-smokers never-smokers 29618728 ES00582 maternal smoking sustained-smokers stopped-smokers 29618728 ES00583 maternal low glycaemic index diet low glycaemic index intervention healthy controls 29642382 ES00584 metabolic syndrome (MetS) metabolic syndrome healthy controls 29643945 ES00585 fiber intake dietary fiber intake 29644791 ES00586 fatigue high fatigue in primary Sjogren’s syndrome low fatigue in primary Sjogren’s syndrome 26966136 ES00587 primary Sjögren's Syndrome (pSS) primary Sjögren’s Syndrome healthy controls 26857698 ES00588 primary Sjögren's Syndrome (pSS) primary Sjögren’s Syndrome healthy controls 26857698 ES00589 primary Sjögren's Syndrome (pSS) primary Sjögren’s syndrome healthy controls 26183421 ES00590 primary Sjögren's Syndrome (pSS) primary Sjögren’s Syndrome healthy controls 26183421 ES00591 primary Sjögren's Syndrome (pSS) primary Sjögren’s Syndrome healthy controls 24574234 ES00592 maternal phthalate exposure high urine concentrations of total phthalate low urine concentrations of total phthalate 29666409 ES00593 breast cancer 29675884 ES00594 asthma asthmatics patients healthy controls 29692198 ES00595 myalgic encephalomyelitis/chronic fatigue syndrome 29692205 ES00596 cognitive impairment cognitive impairment healthy controls 29692214 ES00597 obesity obese/overweight PCa patients normal weight PCa patients 29692867 ES00598 serum immunoglobulin E (IgE) levels serum immunoglobulin E (IgE) levels 29692868 ES00599 maternal smoking maternal smoking during pregnancy never-smokers 29695247 ES00600 psychosis converters non-converters 29695761 ES00601 alcohol consumption consecutive heavy drinkers abstinent controls 29704316 ES00602 parenting stress Parenting Stress Index—Short Form 29707254 ES00603 body mass index (BMI) BMI 29713043 ES00604 waist circumference (WC) WC 29713043 ES00605 waist to hip ratio (WHR) WHR 29713043 ES00606 waist to height ratio (WHtR) WHtR 29713043 ES00607 obesity obese/overweight CRC patients normal weight CRC patients 29717273 ES00608 bevacizumab efficacy in metastatic breast cancer responders non-responders 29721079 ES00609 prenatal bisphenol A (BPA) exposure BPA concentration in serum 29721103 ES00610 prostate cancer prostate cancer adjacent normal tissues 29740534 ES00611 soluble tumor necrosis factor receptor 2 (sTNFR2) levels in plasma soluble tumor necrosis factor receptor 2 (sTNFR2) levels in plasma 29740313 ES00612 body mass index (BMI) BMI 29278407 ES00613 major depression disorder major depression healthy controls 29272728 ES00614 lung carcinoma Surgically resected tumor tissue Bronchial washing 29270240 ES00615 post-traumatic stress disorder (PTSD) trauma symptom inventory scales 29258561 ES00616 perceived racial discrimination Major Life Discrimination (MLD) and the Race-Related Events (RES) scales 29258399 ES00617 Kabuki syndrome (KS) individuals with a Kabuki syndrome diagnosis healthy controls 29255178 ES00618 panic disorder panic disorder patients healthy controls 29249830 ES00619 maternal depression Edinburgh Postnatal Depression Scale and the Montgomery–Asberg Depression Rating Scale 25849984 ES00620 placental microbes Lactobacillus 29240761 ES00621 placental microbes P. bivia 29240761 ES00622 placental microbes G. vaginalis 29240761 ES00623 placental microbes Peptostreptococcus 29240761 ES00624 placental microbes E. coli 29240761 ES00625 placental microbes Alpha streptococcus 29240761 ES00626 placental microbes U. urealitycum 29240761 ES00627 placental microbes Staphylococcus 29240761 ES00628 placental microbes Propionibacterium 29240761 ES00629 placental microbes Actinomyces Sp. 29240761 ES00630 placental microbes Corynebacterium Sp. 29240761 ES00631 placental microbes Staph sp. & Staph Aureus 29240761 ES00632 placental microbes Strepto Group B 29240761 ES00633 placental microbes Strepto Group D 29240761 ES00635 type 2 diabetes (T2D) T2D healthy controls 29228058 ES00637 maternal glycemic response in pregnancy maternal 2-hour glycemia post-load 29752424 ES00638 rheumatoid arthritis (RA) early rheumatoid arthritis non-arthritic patients 29743579 ES00639 rheumatoid arthritis (RA) established, long-standing rheumatoid arthritis non-arthritic patients 29743579 ES00640 rheumatoid arthritis (RA) patients with resolving arthritis non-arthritic patients 29743579 ES00641 multiple risk behaviours cumulative risk score 29172051 ES00642 multiple risk behaviours risky sexual behaviour 29172051 ES00643 multiple risk behaviours lack of exercise 29172051 ES00644 multiple risk behaviours substance use 29172051 ES00645 predispose for traffic-related risk behaviour 29172051 ES00646 predispose for substance use 29172051 ES00647 smoking urine cotinine levels 29166816 ES00648 carboplatin treatment after guadecitabine treatment in patients with recurrent platinum-resistant ovarian cancer before guadecitabine treatment in patients with recurrent platinum-resistant ovarian cancer 29229600 ES00649 vitamin B12 supplement B12 supplementation Placebo 29135286 ES00650 cognitive function cognitive composite score 29311901 ES00651 folic acid and vitamin B12 supplementation folic acid and vitamin B12 supplementation placebo 29135286 ES00652 major depression disorder with depressive symptoms without depressive symptoms 29305581 ES00653 cardiovascular risk cardiovascular risk 29326313 ES00654 response to paroxetine worst responders in major depressive disorder best responders in major depressive disorder 29131015 ES00655 acute coronary syndrome acute coronary syndrome healthy controls 29115576 ES00656 smoking smoking within 5 years never smokers 29109506 ES00657 smoking smoking within 5 years smoking beyond 5 years 29109506 ES00658 oligospermia oligospermic males proven fertile males 29108863 ES00659 intermittent explosive disorder intermittent explosive disorder healthy controls 29106553 ES00660 body mass index (BMI) BMI 29099282 ES00661 waist circumference (WC) WC 29099282 ES00662 gestational diabetes mellitus intrauterine exposure to maternal gestational diabetes healthy sibling pairs 29099273 ES00663 estimated glomerular filtration rate (eGFR) estimated glomerular filtration rate 29097680 ES00664 kidney disease prevalent chronic kidney disease healthy controls 29097680 ES00665 kidney disease incident chronic kidney disease healthy controls 29097680 ES00666 maternal eating disorders active maternal eating disorders healthy controls 29093763 ES00667 maternal eating disorders past maternal eating disorders healthy controls 29093763 ES00668 preeclampsia early-onset preeclampsia pre-term births of varying etiologies 29092053 ES00669 body mass index (BMI) BMI 29084944 ES00670 WHO standardised BMI (ZBMI) ZBMI 29084944 ES00671 absolute fat mass (FM, kg) absolute fat mass 29084944 ES00672 fat mass index (FMI, kg/m²) FMI 29084944 ES00673 absolute fat free mass (FFM, kg) FFM 29084944 ES00674 fat free mass index (FFMI, kg/m²) FFMI 29084944 ES00675 homocysteine levels elevated homocysteine levels (MTHFR 677C>T) healthy controls 29084233 ES00676 homocysteine levels elevated homocysteine levels (genetic-risk score (GRS) based on 18 homocysteineassociated SNPs) 29084233 ES00677 malignant pheochromocytoma (PCC) and paraganglioma (PGL) metastatic tumor primary tumor 29067245 ES00678 aging age 29754148 ES00679 body mass index (BMI) BMI 29762635 ES00680 waist circumference (WC) WC 29762635 ES00681 puberty post-puberty (14 years) pre-puberty (8 years) 29760811 ES00682 puberty post-puberty (14 years) pre-puberty (8 years) 29760811 ES00683 puberty post-puberty (14 years) pre-puberty (8 years) 29760811 ES00684 IL-13 treatment IL-13 treated untreated 26474238 ES00685 nasopharyngeal carcinoma nasopharyngeal carcinoma patients noncancer 26443805 ES00686 facial anomalies syndrome (ICF) facial anomalies syndrome patients healthy controls 26161907 ES00687 pheochromocytoma and paraganglioma (PPGL) PPGL with metastases PPGL without metastases 25825477 ES00688 response to systemic corticosteroid presenting to the Emergency Department 18–24 hours after treatment 29028809 ES00689 response to systemic corticosteroid good responders poor responders 29028809 ES00690 obesity BMI ? 30 kg/m2 BMI < 30 kg/m2 28947923 ES00691 abdominal obesity WC ? 88 cm for women and ? 102 cm for men WC < 88 cm for women and < 102 cm for men 28947923 ES00693 serum dioxins and dioxin-like compounds level serum dioxins and dioxin-like compounds levels 29492303 ES00694 serum polychlorobiphenyls level serum polychlorobiphenyls levels 29492303 ES00695 serum perfluoroctane sulphonate level serum perfluoroctane sulphonate levels 29492303 ES00696 maternal depression high pregnancy anxiety scores low pregnancy anxiety scores 29026448 ES00697 body mass index (BMI) Current BMI 29777239 ES00698 body mass index (BMI) BMI at age 18–21 years 29777239 ES00699 body mass index (BMI) change Current BMI BMI at age 18–21 years 29777239 ES00700 breast cancer breast cancer progression 29776342 ES00701 Juvenile idiopathic arthritis (JIA) JIA healthy controls 28969936 ES00702 preeclampsia early-onset preeclampsia uncomplicated pregnancies, normotensive fetal growth restricted and normotensive preterm birth 28962690 ES00703 preeclampsia early-onset preeclampsia uncomplicated pregnancies, normotensive fetal growth restricted and normotensive preterm birth 28962690 ES00704 thyroid lesion Benign thyroid lesion non-neoplastic thyroid tissues 28938489 ES00705 papillary thyroid carcinoma Papillary thyroid carcinoma non-neoplastic thyroid tissues 28938489 ES00706 follicular thyroid carcinoma Follicular thyroid carcinoma non-neoplastic thyroid tissues 28938489 ES00707 oppositional defiant disorder High irritability/headstrong Low irritability/headstrong 28929496 ES00708 oppositional defiant disorder headstrong subdimension High headstrong Low headstrong 28929496 ES00709 leukoaraiosis (LA) LA type I healthy controls 29875652 ES00710 leukoaraiosis (LA) LA type II LA type I 29875652 ES00711 leukoaraiosis (LA) LA healthy controls 29875652 ES00712 maternal smoking maternal smoking status in pregnancy 29860346 ES00713 metabolic syndrome (MetS) metabolic syndrome healthy controls 29850476 ES00714 hepatocellular carcinoma (HCC) HCC patients normal control 29848370 ES00715 Werner syndrome patients affected by Werner syndrome healthy controls 28861129 ES00716 maternal lead exposure maternal red blood cell lead concentrations 28858830 ES00717 maternal lead exposure maternal red blood cell lead concentrations 28858830 ES00718 maternal lead exposure maternal red blood cell lead concentrations 28858830 ES00719 smoking current smokers never smokers 28854564 ES00720 oral squamous cell carcinoma (OSCC) survival of oral squamous cell carcinoma 28852427 ES00721 Parkinson's disease (PD) PD patients healthy controls 28851441 ES00722 Parkinson's disease (PD) PD patients healthy controls 28851441 ES00723 psychiatric psychiatric healthy controls 28850114 ES00724 intellectual disability intellectual disability healthy controls 28850114 ES00725 behavioral disorders behavioral disorders controls 28850114 ES00726 disorders of psychological development disorders of psychological development controls 28850114 ES00727 schizophrenia schizophrenia healthy controls 28850114 ES00728 sedentary behavior time spent on sedentary behavior 29582722 ES00729 physical activity time spent on light physical activity 29582722 ES00730 maternal pre-pregnancy obesity maternal overweight/obesity (BMI > 25) maternal normal weight (BMI 18.5 to 25) 29016858 ES00731 aging 5 years birth 29064478 ES00732 breast cancer breast cancer risk 26244061 ES00733 smoking pack-years by age 18 29325449 ES00734 childhood sexual victimization sexual victimization not observed in relation to sexual victimization 29325449 ES00735 sexual abuse Retrospective Reports of Sexual Abuse (Childhood Trauma Questionnaire; CTQ) 29325449 ES00736 cognitive function cognitive composite score 29311901 ES00737 cognitive function longitudinal cognition change (over 10-year period) 29311901 ES00738 cognitive function cognitive composite score 29311901 ES00739 cognitive function Longitudinal cognition change (over 10-year period) 29311901 ES00740 cognitive function digit test 29311653 ES00741 cognitive function mini-mental state examination 29311653 ES00742 cognitive function phonemic verbal fluency 29311653 ES00743 cognitive function vocabulary 29311653 ES00744 B-cell chronic lymphocytic leukemia diagnosed with CLL 2.0–15.7 years after enrollment, still healthy 2.0–15.7 years after enrollment, 28903739 ES00745 breast cancer triple-negative subtype luminal A subtype 28899398 ES00746 educational attainment educational attainment 29086770 ES00747 prenatal paracetamol exposure prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder unexposed without attention-deficit/hyperactivity disorder 28785368 ES00748 prenatal paracetamol exposure prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder sporadically exposed with attention-deficit/hyperactivity disorder 28785368 ES00749 prenatal paracetamol exposure prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder unexposed with attention-deficit/hyperactivity disorder 28785368 ES00750 smoking-associated colorectal carcinogenesis tumours from active smokers adjacent mucosa tissue from active smokers 28791728 ES00751 post-traumatic stress disorder (PTSD) post-traumatic stress disorder symptom severity 28795405 ES00752 grandmaternal stress during pregnancy (intimate partner violence) Composite Abuse Scale higher than three Composite Abuse Scale lower than three 28809857 ES00753 grandmaternal stress during pregnancy (domestic violence) exposure to domestic violence not exposure to domestic violence 28809857 ES00754 twin birth siblings born before a twin birth siblings born after a twin birth 28814741 ES00755 adiposity ratio of skinfold thickness (subscapular:triceps) in early childhood 28814982 ES00756 adiposity sum of skinfold thickness (subscapular+triceps) in early childhood 28814982 ES00757 adiposity ratio of skinfold thickness (subscapular:triceps) in mid-childhood 28814982 ES00758 Kashin-Beck disease (KBD) KBD cartilage normal cartilage 28818737 ES00759 osteoarthritis (OA) osteoarthritis cartilage normal cartilage 28818737 ES00760 osteoarthritis (OA) OA patients (high-grade) OA patients (low-grade) 28827734 ES00761 gestational diabetes mellitus women exposed to GDM women unexposed to GDM 28834773 ES00762 gestational diabetes mellitus maternal GDM exposure healthy controls 28834773 ES00763 post- to prefenofibrate treatment ratio for high sensitivity CRP serum concentrations of CRP after fenofibrate treatment serum concentrations of CRP before fenofibrate treatment 28835163 ES00764 post- to prefenofibrate treatment ratio for IL-2 soluble receptor serum concentrations of IL-2 soluble receptor after fenofibrate treatment serum concentrations of IL-2 soluble receptor before fenofibrate treatment 28835163 ES00765 post- to prefenofibrate treatment ratio for IL-6 serum concentrations of IL-6 after fenofibrate treatment serum concentrations of IL-6 before fenofibrate treatment 28835163 ES00766 dilated cardiomyopathy (DCM) patients with DCM healthy controls 28838933 ES00767 prenatal phthalate exposure di-2-ethylhexyl phthalate (DEHP) level in prenatal urine at 13 weeks gestation 28556291 ES00768 prenatal phthalate exposure mono-n-butyl phthalate (MBP) level in prenatal urine at 13 weeks gestation 28556291 ES00769 prenatal phthalate exposure monobenzyl phthalate (MBzP) level in prenatal urine at 13 weeks gestation 28556291 ES00770 prenatal phthalate exposure monocarboxynonyl phthalate (MCNP) level in prenatal urine at 13 weeks gestation 28556291 ES00771 prenatal phthalate exposure mono(3-carboxypropyl) phthalate (MCPP) level in prenatal urine at 13 weeks gestation 28556291 ES00772 prenatal phthalate exposure mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) level in prenatal urine at 13 weeks gestation 28556291 ES00773 prenatal phthalate exposure mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) level in prenatal urine at 13 weeks gestation 28556291 ES00774 prenatal phthalate exposure mono(2-ethylhexyl) phthalate (MEHP) level in prenatal urine at 13 weeks gestation 28556291 ES00775 prenatal phthalate exposure mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) level in prenatal urine at 13 weeks gestation 28556291 ES00776 prenatal phthalate exposure monoethyl phthalate (MEP) level in prenatal urine at 13 weeks gestation 28556291 ES00777 prenatal phthalate exposure di-2-ethylhexyl phthalate (DEHP) level in prenatal urine at 26 weeks gestation 28556291 ES00778 prenatal phthalate exposure high molecular weight (HMW) phthalate metabolite level in prenatal urine at 26 weeks gestation 28556291 ES00779 prenatal phthalate exposure low molecular weight (LMW) phthalate metabolite level in prenatal urine at 26 weeks gestation 28556291 ES00780 prenatal phthalate exposure mono-n-butyl phthalate (MBP) level in prenatal urine at 26 weeks gestation 28556291 ES00781 prenatal phthalate exposure monobenzyl phthalate (MBzP) level in prenatal urine at 26 weeks gestation 28556291 ES00782 prenatal phthalate exposure monocarboxynonyl phthalate (MCNP) level in prenatal urine at 26 weeks gestation 28556291 ES00783 prenatal phthalate exposure mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) level in prenatal urine at 26 weeks gestation 28556291 ES00784 prenatal phthalate exposure mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) level in prenatal urine at 26 weeks gestation 28556291 ES00785 prenatal phthalate exposure mono(2-ethylhexyl) phthalate (MEHP) level in prenatal urine at 26 weeks gestation 28556291 ES00786 prenatal phthalate exposure mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) level in prenatal urine at 26 weeks gestation 28556291 ES00787 prenatal phthalate exposure monoethyl phthalate (MEP) level in prenatal urine at 26 weeks gestation 28556291 ES00788 prenatal phthalate exposure mono-isobutyl phthalate (MiBP) level in prenatal urine at 26 weeks gestation 28556291 ES00789 prenatal phthalate exposure di-2-ethylhexyl phthalate (DEHP) level in prenatal urine at gestation 28556291 ES00790 prenatal phthalate exposure high molecular weight (HMW) phthalate metabolite level in prenatal urine at gestation 28556291 ES00791 prenatal phthalate exposure low molecular weight (LMW) phthalate metabolite level in prenatal urine at gestation 28556291 ES00792 prenatal phthalate exposure mono-n-butyl phthalate (MBP) level in prenatal urine at gestation 28556291 ES00793 prenatal phthalate exposure monobenzyl phthalate (MBzP) level in prenatal urine at gestation 28556291 ES00794 prenatal phthalate exposure monocarboxynonyl phthalate (MCNP) level in prenatal urine at gestation 28556291 ES00795 prenatal phthalate exposure mono(3-carboxypropyl) phthalate (MCPP) level in prenatal urine at gestation 28556291 ES00796 prenatal phthalate exposure mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) level in prenatal urine at gestation 28556291 ES00797 prenatal phthalate exposure mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) level in prenatal urine at gestation 28556291 ES00798 prenatal phthalate exposure mono(2-ethylhexyl) phthalate (MEHP) level in prenatal urine at gestation 28556291 ES00799 prenatal phthalate exposure mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) level in prenatal urine at gestation 28556291 ES00800 prenatal phthalate exposure monoethyl phthalate (MEP) level in prenatal urine at gestation 28556291 ES00801 prenatal phthalate exposure mono-isobutyl phthalate (MiBP) level in prenatal urine at gestation 28556291 ES00802 adrenocortical carcinoma different subtypes of adrenocortical carcinoma 27165744 ES00803 adrenocortical carcinoma overall survival of adrenocortical carcinoma patients 23093492 ES00804 adrenocortical carcinoma adrenocortical carcinoma patients healthy controls 26963385 ES00805 generalized anxiety disorder (GAD) High-risk group Low-risk group 29604450 ES00806 acute myelocytic leukemia (AML) survival time for acute myelocytic leukemia (AML) patients 29933410 ES00807 acute myelocytic leukemia (AML) poor-risk favorable-risk 29933410 ES00808 osteoporosis ostmenopausal osteoporotic women healthy controls 29924424 ES00809 maternal NO2 exposure during pregnancy NO2 hourly concentrations 29935799 ES00810 maternal PM10 exposure PM10 hourly concentrations 29935799 ES00811 systolic blood pressure systolic blood pressure 29930403 ES00812 diastolic blood pressure diastolic blood pressure 29930403 ES00813 mean arterial pressure mean arterial pressure 29930403 ES00814 pulse pressure pulse pressure 29930403 ES00815 endometrial carcinoma endometrial cancer patients healthy controls 29912667 ES00816 endometrial carcinoma overall survival of endometrial cancer 29912667 ES00817 alcohol dependence chronic alcohol dependence patients healthy controls 28747766 ES00818 alcohol treatment post-treatment alcohol dependent patients pre-treatment alcohol dependent patients 28747766 ES00819 ankylosis spondylitis (AS) ankylosis spondylitis patients healthy controls 28743287 ES00820 breast cancer 28415743 ES00821 household socioeconomic status in childhood household socioeconomic status in childhood 28673994 ES00822 extended absence of a parent in childhood extended absence of a parent in childhood 28673994 ES00823 animal feces exposure in infancy animal feces exposure in infancy 28673994 ES00824 blood triglyceride levels serum levels of triglycerides (in mmol/L) 28894120 ES00825 response to dietary stilbenoids exposed to resveratrol at non-cytotoxic 15µM dose for 9 days 29797699 ES00826 childhood obesity obese subjects (mean BMI: 21.67) age/sex matched controls (mean BMI: 14.92) 29797594 ES00827 non-small cell lung carcinoma (NSCLC) NSCLCs hospital-based controls 29796116 ES00828 papillary thyroid carcinoma PTC non-neoplastic adjacent tissues 28469731 ES00829 longevity individuals in Costa Rican high longevity region healthy controls 28465725 ES00830 rheumatoid arthritis (RA) RA patients healthy controls 28475762 ES00831 pan-cancer methylation dysregulation index in pan-cancer 28426276 ES00832 obesity obesity normal BMI 29956501 ES00833 obesity obesity normal BMI 29956501 ES00834 amount of visceral adipose tissue amount of visceral adipose tissue 29956501 ES00836 prenatal arsenic exposure concentration of inorganic As species in urine 29947889 ES00837 prenatal arsenic exposure concentration of inorganic As species in urine 29947889 ES00838 prenatal arsenic exposure concentration of inorganic As species in urine 29947889 ES00839 maternal smoking maternal smoking during pregnancy 29945474 ES00840 serum immunoglobulin E (IgE) levels high IgE Low IgE 25707804 ES00841 schizophrenia patients with schizophrenia healthy controls 27074206 ES00842 myocardial infarction individuals with a history of myocardial infarction healthy controls 28172975 ES00843 acute respiratory distress syndrome (ARDS) 28-day survival of acute respiratory distress syndrome 29511782 ES00844 blood fasting very-lowdensity lipoprotein cholesterol levels blood fasting very-lowdensity lipoprotein cholesterol levels 24920721 ES00845 blood triglyceride levels blood triglyceride levels 24920721 ES00846 cow's milk allergy children with cow's milk allergy nonallergic and nonatopic children 27236499 ES00847 maternal smoking maternal smoking during pregnancy 25325234 ES00848 serum immunoglobulin E (IgE) levels serum immunoglobulin E (IgE) levels 28069425 ES00849 plasma resistin levels plasma resistin levels 26404063 ES00850 hypertriglyceridemic waist hypertriglyceridemia 26798409 ES00851 triglyceride postprandial responses to a high-fat dietary challenge TG-PPL respons 27777315 ES00852 body mass index (BMI) BMI 27564309 ES00853 blood triglyceride levels blood triglyceride levels 28194238 ES00854 blood high-density lipoprotein (HDL) levels blood high-density lipoprotein cholesterol levels 28194238 ES00855 lung function lung function (FEV1/FVC) 28621160 ES00856 lung function lung function (forced vital capacity, FVC) 28621160 ES00857 lung function lung function (forced expiratory volume the first second, FEV1) 28621160 ES00858 body mass index (BMI) BMI 26110892 ES00859 waist circumference (WC) WC 26110892 ES00860 maternal smoking levels of cotinine > 7.5 ng/g in utero levels of cotinine < 7.5 ng/g in utero 25482056 ES00861 panic disorder panic disorder patients healthy controls 28149334 ES00862 tic disorders tic disorders patients healthy controls 26499864 ES00863 bone mineral density (BMD) bone mineral density 28394087 ES00864 maternal smoking children exposed to maternal smoking children unexposed to maternal smoking 25862628 ES00865 Trihalomethanes (THM) exposure exposed to average lifetime THM levels >85 ?g/L exposed to average lifetime THM levels ?85 ?g/L 26039576 ES00866 prenatal exposure to maternal stress prenatal maternal stress exposure (PMSE) score 26889969 ES00867 in utero arsenic exposure placental arsenic levels 26771251 ES00868 myocardial infarction myocardial infarction patients healthy controls 28515798 ES00869 Parkinson's disease (PD) parkinson's disease patients healthy controls 25304910 ES00870 folic acid supplement during pregnancy maternal plasma folate during pregnancy 26861414 ES00871 maternal smoking maternal smoking status in pregnancy 27171005 ES00872 cardiac autonomic responses (deceleration capacity) deceleration capacity 28075199 ES00873 cardiac autonomic responses (acceleration capacity) acceleration capacity 28075199 ES00874 body mass index (BMI) BMI 27773939 ES00875 psoriasis psoriasis patients healthy controls 26743604 ES00876 total cholesterol serum cholesterol concentrations 28173150 ES00877 blood high-density lipoprotein (HDL) levels blood high-density lipoprotein cholesterol levels 28173150 ES00878 serum immunoglobulin E (IgE) levels serum immunoglobulin E (IgE) levels 28322575 ES00879 serum liver enzyme levels (gamma-glutamyl transferase, GGT) serum GGT levels 28624579 ES00880 serum liver enzyme levels (alanine aminotransferase, ALT) serum ALT levels 28624579 ES00881 hepatic steatosis hepatic steatosis patients healthy controls 28624579 ES00882 inflammatory bowel disease inflammatory bowel disease patients healthy controls 27886173 ES00883 body mass index (BMI) BMI 27826092 ES00884 serum 25-hydroxyvitamin D levels serum 25-hydroxyvitamin D levels 27035505 ES00885 plasma fasting insulin levels plasma fasting insulin levels 24170695 ES00886 plasma fasting HOMA-IR levels plasma fasting HOMA-IR levels 24170695 ES00887 metabolic trait blood X-11491 levels 24014485 ES00888 metabolic trait blood Chylo-A levels 24014485 ES00889 metabolic trait blood PC ae C36:5 levels 24014485 ES00890 metabolic trait blood Glycine levels 24014485 ES00891 metabolic trait blood SM C16:0 levels 24014485 ES00892 metabolic trait blood Arg levels 24014485 ES00893 metabolic trait blood VLDL-A levels 24014485 ES00894 metabolic trait blood 17beta-diol disulfate levels 24014485 ES00895 metabolic trait blood 4-vinylphenol sulfate levels 24014485 ES00896 breast cancer women who developed breast cancer 0 to 5 years after enrollment women who remained cancer free 23578854 ES00897 Behcet's disease Behçet's disease ptients healthy controls 24574333 ES00898 Behcet's disease Behçet's disease ptients healthy controls 24574333 ES00899 depressive disorder depression scale 29998287 ES00900 childhood stress scores of Youth Life Stress Interview 30018309 ES00901 chronic obstructive pulmonary disease (COPD) never smokers with COPD never smokers without COPD 30018765 ES00902 chronic obstructive pulmonary disease (COPD) current smokers with COPD current smokers without COPD 30018765 ES00903 17q12 deletion 17q12 deletion healthy controls 30021660 ES00904 arsenic exposure arsenic exposure arsenic non-exposure 29982128 ES00905 prenatal phthalate exposure low molecular weight (LMW) phthalate metabolite level in prenatal urine at 13 weeks gestation 28556291 ES00906 lung carcinoma three consecutive years from three patients (2 years before, 1 year before, and after lung cancer detection) 30302959 ES00907 systemic lupus erythematosus (SLE) patients with SLE healthy controls 30301579 ES00908 systemic lupus erythematosus (SLE) patients with SLE (disease activity index<=6) healthy controls 30301579 ES00909 systemic lupus erythematosus (SLE) patients with SLE (disease activity index>6) healthy controls 30301579 ES00910 systemic lupus erythematosus (SLE) patients with SLE (European American) healthy controls 30301579 ES00911 systemic lupus erythematosus (SLE) patients with SLE (African American) healthy controls 30301579 ES00912 air pollution (PM2.5) PM2.5 exposure groups control group 30286548 ES00913 child abuse experience of childhood abuse (none, medium and high) 30279435 ES00914 nonalcoholic fatty liver disease (NAFLD) nonalcoholic fatty liver disease patients healthy controls 30270343 ES00915 simple hepatic steatosis simple hepatic steatosis patients healthy controls 30270343 ES00916 aging old Swedish twins 30264654 ES00918 organophosphate exposure yearly average organophosphate exposure 30248838 ES00919 overall survival of colorectal cancer overall survival of colorectal cancer 30248669 ES00920 chronic obstructive pulmonary disease (COPD) COPD patients healthy controls 30248490 ES00921 infertility oligozoospermic infertile patients normozoospermic fertile controls 30239288 ES00922 recurrent stroke previous number of strokes 30237808 ES00923 plasma homocysteine (Hcy) levels plasma homocysteine (Hcy) levels 30237808 ES00924 residential proximity to major roadways at birth residential proximity to major roadways at birth 30226399 ES00925 household socioeconomic status in childhood 30351206 ES00926 household socioeconomic status in childhood 30351206 ES00927 household socioeconomic status in childhood 30351206 ES00928 smoking pack-years 30390659 ES00929 smoking current smokers never smokers 30390659 ES00930 acute chorioamnionitis (aCA) aCA cases non-aCA cases 30373633 ES00931 blood protein biomarker levels Adrenomedullin levels 28915241 ES00932 blood protein biomarker levels CCL19 levels 28915241 ES00933 blood protein biomarker levels CCL4 levels 28915241 ES00934 blood protein biomarker levels CHI3L1 levels 28915241 ES00935 blood protein biomarker levels CX3CL1 levels 28915241 ES00936 blood protein biomarker levels CXCL1 levels 28915241 ES00937 blood protein biomarker levels CXCL11 levels 28915241 ES00938 blood protein biomarker levels CXCL13 levels 28915241 ES00939 blood protein biomarker levels CXCL9 levels 28915241 ES00940 blood protein biomarker levels Cystatin B levels 28915241 ES00941 blood protein biomarker levels Dkk-1 levels 28915241 ES00942 blood protein biomarker levels ECP levels 28915241 ES00943 blood protein biomarker levels ESM-1 levels 28915241 ES00944 blood protein biomarker levels FGF-23 levels 28915241 ES00945 blood protein biomarker levels Flt3L levels 28915241 ES00946 blood protein biomarker levels Follistatin levels 28915241 ES00947 blood protein biomarker levels GAL levels 28915241 ES00948 blood protein biomarker levels GDF-15 levels 28915241 ES00949 blood protein biomarker levels HB-EGF levels 28915241 ES00950 blood protein biomarker levels IL-12 levels 28915241 ES00951 blood protein biomarker levels IL17RB levels 28915241 ES00952 blood protein biomarker levels IL-18 levels 28915241 ES00953 blood protein biomarker levels IL27-A levels 28915241 ES00954 blood protein biomarker levels IL6RA levels 28915241 ES00955 blood protein biomarker levels mAmP levels 28915241 ES00956 blood protein biomarker levels MIA levels 28915241 ES00957 blood protein biomarker levels MIC-A levels 28915241 ES00958 blood protein biomarker levels Midkine levels 28915241 ES00959 blood protein biomarker levels MMP-12 levels 28915241 ES00960 blood protein biomarker levels NEMO levels 28915241 ES00961 blood protein biomarker levels PlGF levels 28915241 ES00962 blood protein biomarker levels RAGE levels 28915241 ES00963 blood protein biomarker levels RETN levels 28915241 ES00964 blood protein biomarker levels SRC levels 28915241 ES00965 blood protein biomarker levels ST2 levels 28915241 ES00966 blood protein biomarker levels TIM levels 28915241 ES00967 blood protein biomarker levels TM levels 28915241 ES00968 blood protein biomarker levels TNF-RI levels 28915241 ES00969 blood protein biomarker levels TNFRSF4 levels 28915241 ES00970 blood protein biomarker levels t-PA levels 28915241 ES00971 blood protein biomarker levels TRAIL levels 28915241 ES00972 blood protein biomarker levels VEGF-A levels 28915241 ES00973 blood protein biomarker levels WFDC2 levels 28915241 ES00974 autism spectrum disorders (ASD) ASD patients healthy controls 29988321 ES00975 hepatocellular carcinoma (HCC) tumor tissues corresponding adjacent normal tissues 29988590 ES00976 rheumatoid arthritis (RA) DNA methylation variability of RA cases DNA methylation variability of normal cases 30176915 ES00977 rheumatoid arthritis (RA) RA cases monozygotic twins normal controls 30176915 ES00978 obesity median BMI 37.04 median BMI 18.88 30397228 ES00979 IgG glycosylation UPLC and LC/MS measured IgG N-glycans 29055820 ES00980 Fuchs Endothelial Corneal Dystrophy (FECD) FECD patients healthy controls 28384203 ES00981 air pollution (PM2.5) PM2.5 treated non-exposure control 30308865 ES00982 smoking current smokers non-smokers 30342560 ES00983 facial aging perceived age of facial images 30409196 ES00984 depressive disorder individuals with a self-reported history of depression individuals without a history of depression 29790996 ES00985 preterm birth preterm samples term samples 29983834 ES00986 maternal stress prenatal maternal stress 30001177 ES00987 Alzheimer's disease (AD) burden of AD pathology 25129075 ES00988 body mass index (BMI) BMI z-score 30412002 ES00989 type 2 diabetes (T2D) T2D cases healthy controls 30107520 ES00990 blood HbA1c levels T2D cases healthy controls 30107520 ES00991 cardio-metabolic risk score cardio-metabolic risk 30412002 ES00992 metabolic trait 5meTHF concentrations in cord blood 30442960 ES00993 metabolic trait dimethylglycine (DMG) at delivery 30442960 ES00994 metabolic trait dimethylglycine (DMG) in cord blood 30442960 ES00995 lung carcinoma lung cancer patients healthy controls 30425263 ES00996 Coffin–Siris syndrome (CSS) patients with mutations in ARID1B age-matched controls 30459321 ES00997 Coffin–Siris syndrome (CSS) patients with mutations in SMARCB1 age-matched controls 30459321 ES00998 Nicolaides–Baraitser syndrome (NCBRS) patients with mutations in SMARCA2 age-matched controls 30459321 ES00999 major depression disorder DNA methylation variability of depression cases DNA methylation variability of normal cases 30458022 ES01000 multiple sclerosis relapsing-remitting multiple sclerosis patients healthy controls 30479356 ES01001 maternal corticotropin-releasing hormone level maternal CRH levels 30464231 ES01002 coronary artery disease (CAD) CAD positive cases CAD negative controls 30470965 ES01003 antiphospholipid syndrome antiphospholipid syndrome patients healthy controls 30471352 ES01004 systemic lupus erythematosus (SLE) patients with SLE healthy controls 30471352 ES01005 low density lipoprotein (LDL) measure concentration of small particles 24711635 ES01006 low density lipoprotein (LDL) measure total particles 24711635 ES01007 low density lipoprotein (LDL) measure average diameter 24711635 ES01008 very low density lipoprotein (LDL) measure concentration of large particles 24711635 ES01009 very low density lipoprotein (LDL) measure concentration of medium particles 24711635 ES01010 very low density lipoprotein (LDL) measure total particles 24711635 ES01011 metabolic syndrome (MetS) individuals with metabolic syndrome individuals without metabolic syndrome 26808626 ES01012 blood triglyceride levels blood triglyceride levels 27350042 ES01013 blood low density lipoprotein (LDL) levels ow-density lipoprotein (LDL) cholesterol levels 27350042 ES01014 blood high-density lipoprotein (HDL) levels blood high-density lipoprotein (HDL) levels 27350042 ES01017 plasma adiponectin levels plasma adiponectin levels 28139377 ES01018 post-traumatic stress disorder (PTSD) trauma-exposed participants trauma-unexposed participants 30456986 ES01019 lung function lung function (FVC, FEV1, FEF25–75%) 30343628 ES01020 infertility oligo-/oligoastheno-zoospermic infertile patients normozoospermic fertile men 30358834 ES01021 parental mental illness parental mental illness 30510187 ES01022 childhood illness childhood illness 30510187 ES01023 child abuse child abuse 30510187 ES01024 myalgic encephalomyelitis/chronic fatigue syndrome ME/CFS diagnosed patients healthy controls 30516085 ES01025 cystic fibrosis CF subjects healthy controls 30526669 ES01026 smoking HIV-positive smokers HIV-positive non-smokers 30545403 ES01027 HIV frailty VACS index of greater than 50 VACS index of less than 50 30545403 ES01028 metformin use after metformin intake before starting a metformin therapy 30545422 ES01029 childhood asthma asthma cases healthy controls 30579849 ES01030 childhood asthma asthma cases healthy controls 30579849 ES01031 atopy atopy no atopy 30584054 ES01032 atopic asthma atopic asthma non-atopic controls 30584054 ES01033 preterm birth spontaneous preterm births term births 30606219 ES01034 preterm birth spontaneous preterm births term births 30606219 ES01035 incident myocardial infarction occurrence incident myocardial infarction occurrence 30587240 ES01036 smoking serum cotinine (ng/ml) 30611298 ES01037 maternal education maternal education 30590607 ES01038 maternal education maternal education 30590607 ES01039 oral squamous cell carcinoma overall survival overall survival 30548666 ES01040 epithelial ovarian cancer risk epithelial ovarian cancer risk 30559148 ES01041 alcohol-associated epithelial ovarian cancer risk epithelial ovarian cancer risk 29321518 ES01042 epithelial ovarian cancer (EOC) EOC cases age-matched controls 24853948 ES01043 epithelial ovarian cancer (EOC) EOC cases healthy controls 24774302 ES01044 epithelial ovarian cancer overall survival epithelial ovarian cancer overall survival 24774302 ES01045 epithelial ovarian cancer (EOC) EOC cases age-matched controls 24479488 ES01046 epithelial ovarian cancer (EOC) pre-treatment ovarian cancer cases healthy controls 20019873 ES01047 circadian rhythm oscillating cytosine modifications 30606238 ES01048 ancestry European descent African descent 30563547 ES01049 congenital hypopituitarism congenital hypopituitarism patients age-matched controls 30365064 ES01050 response to corticosteroid in acute exacerbation chronic obstructive pulmonary disease patients good response poor response 29329142 ES01051 myalgic encephalomyelitis/chronic fatigue syndrome ME/CFS patients healthy controls 30036399 ES01052 dimethyl fumarate treatment in multiple sclerosis patients 6 months DMF treatment before DMF treatment 30038789 ES01053 aging old individuals young individuals 30045751 ES01054 aging old individuals young individuals 30045751 ES01055 Alzheimer's disease (AD) Braak stage 30045751 ES01056 Alzheimer's disease (AD) Braak stage 30045751 ES01057 air pollution (PM2.5) personal exposure to PM2.5 30055357 ES01058 physical frailty frail not frail 30075802 ES01059 short-term PM2.5 exposure PM2.5 exposure levels (53.1 ?g/m3) PM2.5 exposure levels (24.3 ?g/m3) 30081103 ES01060 cystic fibrosis cystic fibrosis patients healthy controls 30052057 ES01061 cystic fibrosis severe cystic fibrosis patients mild cystic fibrosis patients 30052057 ES01062 lung function FEV1% 30052057 ES01063 sex-related differences in chronic lymphocytic leukemia median_CLLMale - median_CLLFemale median_conMale - median_conFemale 30616686 ES01064 maternal pre-pregnancy body mass index (BMI) maternal pre-pregnancy BMI 30618290 ES01065 maternal pre-pregnancy obesity BMI ?30 kg/m2 BMI <30 kg/m2 30618290 ES01066 maternal pre-pregnancy waist circumference (WC) maternal pre-pregnancy WC 30618290 ES01067 maternal pre-pregnancy waist to hip ratio (WHR) maternal pre-pregnancy WHR 30618290 ES01068 maternal pre-pregnancy central obesity WHR ? 0.85 WHR < 0.85 30618290 ES01069 maternal pre-pregnancy sum of skinfolds maternal pre-pregnancy SST 30618290 ES01070 maternal pre-pregnancy serum leptin serum leptin 30618290 ES01071 aging 10 years old 5 years old 30626398 ES01072 aging 5 years old birth 30626398 ES01073 educational attainment educational attainment 30631468 ES01074 psoriasis psoriasis patients adjacent normal tissues 30092825 ES01075 riboflavin intake intake of riboflavin 30101351 ES01076 suicide attempt in schizophrenia schizophrenia suicide attempters schizophrenia nonsuicide attempters 30103066 ES01077 polycystic ovary syndrome (PCOS) women with PCOS age-, weight-, and body mass index?matched controls 30113663 ES01078 breast cancer risk susceptibility to breast cancer 29491469 ES01079 frailty index frailty index consists of 22 health and function variables 30136078 ES01080 urinary nicotine equivalents urinary nicotine equivalents 30139389 ES01081 Huntington's disease (HD) HD mutation carriers healthy controls 30158895 ES01082 Huntington's disease (HD) symptomatic mutation carriers pre-symptomatic patients 30158895 ES01083 Huntington's disease (HD) symptomatic HD mutation carriers healthy controls 30158895 ES01084 Huntington's disease (HD) per-symptomatic HD mutation carriers controls 30158895 ES01085 childhood biobehavioral reactivity disinhibited inhibited 30176105 ES01086 childhood biobehavioral reactivity disinhibited inhibited 30176105 ES01087 urological cancer urological cancer normal control 30182734 ES01088 renal clear cell carcinoma survival renal clear cell carcinoma survival 30182734 ES01089 bladder cancer survival bladder urothelial carcinoma survival 30182734 ES01090 colorectal cancer colorectal cancer normal control 30183087 ES01091 colorectal laterally spreading tumor colorectal laterally spreading tumor normal control 30183087 ES01092 adenoma adenoma cases normal control 30183087 ES01093 age-related macular degeneration (AMD) AMD normal controls 30642396 ES01094 perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure people perinatal exposed to high PCBs and PCDFs referents 30640082 ES01095 short-term diesel exhaust inhalation diesel exhaust exposures filtered air exposures 25487561 ES01096 gestational diabetes mellitus GDM offspring healthy controls 30185669 ES01097 Klinefelter syndrome KS female controls 30213969 ES01098 Klinefelter syndrome KS male controls 30213969 ES01099 smoking ever smoking never smoking 30215712 ES01100 smoking smoking at least one cigarette per week never having smoked or less than weekly 30215712 ES01101 smoking at least one cigarette smoked weekly at any of the three questionnaires never smoked at least weekly 30215712 ES01102 smoking cotinine in the blood 30215712 ES01103 smoking time since the individual first ever smoked 30215712 ES01104 asthma current asthma at 7.5 years healthy controls 29046734 ES01105 wheeze current wheeze status at 7.5 years 29046734 ES01106 asthma current asthma at 16.5 years healthy controls 29046734 ES01107 asthma ever asthma at 16.5 years healthy controls 29046734 ES01108 wheeze ever wheeze at 16.5 years healthy controls 29046734 ES01109 type 2 diabetes (T2D) T2D patients no T2D control 30649532 ES01110 type 2 diabetes (T2D) T2D patients with HIV-infected no T2D patients with HIV-infected 30649532 ES01111 gender women myoblasts men myoblasts 30646953 ES01112 gender women myotubes men myotubes 30646953 ES01113 polybrominated biphenyl exposure total PBB levels 30676242 ES01114 Amyloid-? plaques Amyloid-? plaques 30660039 ES01115 neurofibrillary tangles neurofibrillary tangles 30660039 ES01118 physical activity total physical activity 30376510 ES01119 physical activity Leisure-time physical activity 30376510 ES01120 television viewing time Television viewing time (hours/day) 30376510 ES01121 chronic beryllium disease chronic beryllium disease beryllium sensitized 30141971 ES01122 early recurrence of serous ovarian cancer recurrence ?12 months recurrence >12 months 30633424 ES01123 mammographic density measure dense area 30694562 ES01124 mammographic density measure non-dense area 30694562 ES01125 mammographic density measure percent dense area 30694562 ES01126 response to preoperative chemoradiation therapy Youden index 25680604 ES01127 frequency of heavy vehicle traffic frequency of heavy vehicle traffic 30697444 ES01128 pan-cancer cancer tissues adjacent normal tissues 30696380 ES01129 Alzheimer's disease (AD) late-onset AD patients neurotypical controls 30712078 ES01130 endometriosis endometriotic lesions adjacent normal tissues 30740831 ES01131 endometriosis ovarian endometriosis age?matched endometriosis?free controls 30740831 ES01132 mortality all-cause mortality 30736859 ES01133 psychotic experience psychotic experience at age 12 no psychotic experience at age 12 30718501 ES01134 psychotic experience psychotic experience at age 12 no psychotic experience at age 12 30718501 ES01135 psychotic experience psychotic experience at age 18 no psychotic experience at age 18 30718501 ES01136 psychotic experience psychotic experience at age 18 no psychotic experience at age 18 30718501 ES01137 psychotic experience psychotic experience at age 12 no psychotic experience at age 12 30718501 ES01138 psychotic experience psychotic experience at age 18 no psychotic experience at age 18 30718501 ES01139 insufficient sleep insufficient sleep 30718923 ES01140 maternal exposure to heavy metals maternal exposure to heavy metals 30763874 ES01141 allergic sensitization allergic sensitization no allergic sensitization 30762239 ES01142 gingival bleeding gingival bleeding no gingival bleeding 30760334 ES01143 tooth mobility tooth mobility no tooth mobility 30760334 ES01144 hepatocellular carcinoma overall survival overall survival of hepatocellular carcinoma 30766752 ES01145 smoking ever-smoker never smokers 30764717 ES01146 hormone therapy ever users never users 30821641 ES01147 glucocorticoid exposure before glucocorticoid exposure after glucocorticoid exposure 30821055 ES01148 air pollution (PM10) average concentrations of PM10 30819252 ES01149 air pollution (NO2) average concentrations of NO2 30819252 ES01150 blood triglyceride levels serum triglyceride levels 30813608 ES01151 systemic lupus erythematosus (SLE) paediatric-onset systemic lupus erythematosus patients healthy controls 30806140 ES01153 childhood adversity caregiver physical or emotional abuse at 6 years of age unexposed group 30905381 ES01154 childhood adversity sexual or physical abuse in childhood unexposed group 30905381 ES01155 childhood adversity maternal psychopathology in childhood unexposed group 30905381 ES01156 childhood adversity one adult in the household in childhood unexposed group 30905381 ES01157 childhood adversity family instability in childhood unexposed group 30905381 ES01158 childhood adversity financial stress in childhood unexposed group 30905381 ES01159 childhood adversity neighborhood disadvantage in childhood unexposed group 30905381 ES01160 childhood obesity obese subjects Non-Obese Controls 30909978 ES01161 insulin resistance IR measured by the Homeostatic Model Assessment of IR (HOMA-IR) 30792424 ES01162 cultured on sandblasted, large-grit, acid-etched (SLA)-treated titanium profiling of hBMSCs on SLA-treated Ti rofiling of hBMSCs on machined smooth Ti 30791149 ES01163 Crohn's disease (CD) patients with Crohn disease (at diagnosis) participants without intestinal inflammation or symptoms 30779925 ES01164 polychlorinated biphenyls (PCBs) exposure PCB118 30776747 ES01165 polychlorinated biphenyls (PCBs) exposure PCB138 30776747 ES01166 polychlorinated biphenyls (PCBs) exposure PCB153 30776747 ES01167 polychlorinated biphenyls (PCBs) exposure PCB156 30776747 ES01168 polychlorinated biphenyls (PCBs) exposure PCB170 30776747 ES01169 polychlorinated biphenyls (PCBs) exposure PCB180 30776747 ES01170 polychlorinated biphenyls (PCBs) exposure DDE 30776747 ES01171 polychlorinated biphenyls (PCBs) exposure HCB 30776747 ES01172 coronary artery disease (CAD) coronary artery disease patients healthy controls 30844764 ES01173 thymic epithelial tumor overall survival overall survival prognosis in patients with thymic epithelial tumors 30832724 ES01174 orofacial cleft orofacial cleft patients healthy controls 30832715 ES01175 orofacial cleft cleft lip 30832715 ES01176 orofacial cleft cleft palate 30832715 ES01177 orofacial cleft cleft lip and palate 30832715 ES01178 right insular surface area right insular surface area 30830696 ES01179 alcohol use disorder (AUD) alcohol use disorder subjects healthy controls 30830696 ES01180 Kawasaki disease (KD) Kawasaki disease patients healthy controls 30861201 ES01181 myopia myopia patients healthy controls 30858441 ES01182 neurodevelopmental presentations and congenital anomalies (ND/CAs) ND/CAs patients healthy controls 30929737 ES01183 birth weight birthweight 31015461 ES01184 alcohol consumption alcohol exposure classification 30938765 ES01185 alcohol consumption alcohol daily intake non-alcohol consumers 30940212 ES01186 colorectal cancer overall survival overall survival of colorectal cancer 29101262 ES01187 autoimmune diseases Graves’ disease, rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis patients healthy controls 31024609 ES01188 autoimmune diseases Graves’ disease, rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis patients healthy controls 31024609 ES01189 alcohol consumption alcohol exposure classification 30938765 ES01190 smoking current smoker with carotid endarterectomy former or never smokers with carotid endarterectomy 30354327 ES01191 smoking current smoker with carotid endarterectomy former or never smokers with carotid endarterectomy 30354327 ES01192 lifetime estrogen exposure estimated lifetime estrogen exposure 31039828 ES01193 hepatocellular carcinoma (HCC) HCC patients adjacent non-tumor tissues 31038805 ES01194 community and domestic violence experience with community and domestic violence experience without community and domestic violence experience 31059136 ES01195 cerebral palsy cerebral palsy patients healthy controls 31035542 ES01196 maternal circadian disruption night shift workers non-night shift workers 31026301 ES01197 Behcet's disease BD patients healthy controls 30863869 ES01198 lung function lung function level and its change 31073081 ES01199 multiple sclerosis MS-affected MZ co-twins Non-affected MZ co-twins 31064978 ES01200 maternal depression Edinburgh Postnatal Depression Scale 31070508 ES01201 maternal socioeconomic status Cumulative score 31062658 ES01202 maternal socioeconomic status Marital status 31062658 ES01203 maternal education maternal education 31062658 ES01204 maternal socioeconomic status Insurance status 31062658 ES01205 infertility azoospermic and oligozoospermic infertile patients normozoospermic fertile controls 31103287 ES01206 exercise before acute aerobic exercise after acute aerobic exercise 31109152 ES01207 cocaine and crack dependents cocaine use disorders patients healthy control 31116258 ES01208 maternal famine exposure in utero exposed to famine healthy controls 31097004 ES01209 ankylosing spondylitis ankylosing spondylitis patients osteoarthritis patients 31128893 ES01210 ankylosing spondylitis patients who carry HLA-B*27 patients who are HLA-B*27 negative 31128893 ES01211 arsenic exposure urinary arsenic 31135185 ES01212 folic acid and vitamin B12 supplementation folate intake 31165884 ES01213 amyotrophic lateral sclerosis amyotrophic lateral sclerosis patients healthy controls 31164693 ES01214 maternal rheumatoid arthritis born to mothers with RA born to mothers without RA 31142478 ES01215 early onset intracranial atherosclerotic stenosis patients with early-onset ICAS healthy controls 31142690 ES01216 plasma fasting glucose levels plasma fasting glucose levels 31197173 ES01217 plasma fasting insulin levels plasma fasting insulin levels 31197173 ES01218 maternal hypertensive disorders in pregnancy maternal hypertensive disorders in pregnancy healthy controls 31230546 ES01219 preeclampsia early-onset preeclampsia (EOPET) healthy controls 31230546 ES01220 plasma fasting HOMA-IR levels insulin-resistant (HOMA-IR ? 2.0) insulin-sensitive (HOMA-IR < 2.0) 31253200 ES01221 Werner syndrome patients affected by Werner syndrome age? and sex?matched controls 31259468 ES01222 air pollution (NO2) NO2 exposure 31260916 ES01223 air pollution (PM2.5) PM2.5 concentration 31260916 ES01224 osteonecrosis of the femoral head (ONFH) ONFH patients healthy controls 31233934 ES01225 nasopharyngeal carcinoma nasopharyngeal carcinoma patients healthy controls 31240455 ES01226 trichloroethylene exposure trichloroethylene exposure 31241004 ES01227 calculated insulin sensitivity index (CSi) CSi 31208038 ES01228 air pollution (PM10) PM10 exposure 31208937 ES01229 waist circumference (WC) waist circumference 31212707 ES01230 colorectal cancer colorectal cancer patients adjacent normal tissues 30846004 ES01231 Alzheimer's disease (AD) Alzheimer's disease patients healthy controls 30898171 ES01232 allergic sensitization mid-childhood atopic sensitization healthy controls 30876376 ES01233 allergic sensitization environmental sensitization healthy controls 30876376 ES01234 allergic sensitization food allergen sensitization healthy controls 30876376 ES01235 risk of future coronary heart disease developed CHD during a mean follow-up of 11.2 years healthy controls 31424985 ES01236 risk of future myocardial infarction developed myocardial infarction during a mean follow-up of 11.2 years healthy controls 31424985 ES01237 systemic lupus erythematosus (SLE) patients with systemic lupus erythematosus healthy controls 31428085 ES01238 primary Sjögren's Syndrome (pSS) patients with primary Sjögren's Syndrome healthy controls 31428085 ES01239 systemic lupus erythematosus (SLE) patients with SLE healthy controls 31430064 ES01240 mixed connective tissue disease (MCTD) patients with MCTD healthy controls 31440254 ES01241 maternal polychlorinated biphenyls (PCBs) exposure PCB levels in cord serum 31382687 ES01242 maternal polychlorinated biphenyls (PCBs) exposure PCB levels in cord serum 31382687 ES01243 alcohol consumption alcohol consumption 31386212 ES01244 major depression disorder cases with depression and sleep symptoms healthy controls 31395523 ES01245 ancestry self-reported ethnicity/race (African, Asian, Caucasian) 31399127 ES01246 childhood asthma children with asthma healthy controls 31300640 ES01247 fractional exhaled nitric oxide fractional exhaled nitric oxide 31300640 ES01248 allergic asthma children with allergic rhinitis healthy controls 31300640 ES01249 bronchodilator response bronchodilator response 31300640 ES01250 smoking smoking status 31303497 ES01251 perinatally-acquired HIV children with perinatally-acquired HIV on antiretroviral therapy healthy controls 31324826 ES01252 papillary thyroid carcinoma papillary thyroid carcinoma patients non-neoplastic thyroid tissue samples 31328658 ES01253 follicular thyroid carcinoma Follicular thyroid carcinoma patients healthy controls 31328658 ES01254 Bacteroidetes-to-Firmicutes (BFR) ratio in stool HighBFR group (BFR > 2.5) LowBFR group (BFR < 1.2) 31333715 ES01255 Bacteroidetes-to-Firmicutes (BFR) ratio in stool HighBFR group LowBFR group 31333715 ES01256 non-small cell lung carcinoma (NSCLC) patients diagnosed with non-small-cell lung cancer healthy controls 31450665 ES01257 non-small cell lung carcinoma (NSCLC) non-small-cell lung cancer in current smokers healthy controls 31450665 ES01258 non-small cell lung carcinoma (NSCLC) non-small-cell lung cancer in nonsmokers healthy controls 31450665 ES01259 smoking smoking status in Non-Small-Cell Lung Cancer patient 31450665 ES01260 smoking smoking status 31450665 ES01261 non-small cell lung carcinoma (NSCLC) stage I NSCLC healthy controls 31450665 ES01262 prenatal bisphenol A (BPA) exposure BPA concentrations in cord blood 31451752 ES01263 prenatal bisphenol A (BPA) exposure BPA concentrations in cord blood (male) 31451752 ES01264 prenatal bisphenol A (BPA) exposure BPA concentrations in cord blood (female) 31451752 ES01265 telomere length leukocyte telomere length 31461406 ES01266 responses to PD-1/PD-L1 inhibition blockade objective response rates 31475034 ES01267 major depression disorder depression symptomatology in elderly monozygotic twins 31477683 ES01268 treated with assisted reproductive technology ART-conceived individuals non-ART conceived individuals 31477727 ES01269 treated with assisted reproductive technology ART-conceived individuals non-ART conceived individuals 31477727 ES01270 adult high-functioning autism spectrum disorder (ASD) adult patients with high-functioning ASD healthy controls 31541176 ES01271 aging age 31546163 ES01272 lung cancer risk lung cancer patient before diagnosis healthy controls 31549173 ES01273 multiple system atrophy patients with multiple system atrophy healthy controls 31535203 ES01274 sarcopenic sarcopenic women age-matched non-sarcopenic women 31508907 ES01275 prenatal socioeconomic status socioeconomic status index 31509016 ES01276 breast cancer overall survival low-risk groups high-risk groups 31520283 ES01277 maternal smoking maternal smoking status in pregnancy 31262328 ES01278 opioid dependence (OD) opioid dependence cases opioid-exposed controls 30874594 ES01279 smoking current smokers never smokers 30872662 ES01280 smoking Former Smokers (?15 Years) never smokers 30872662 ES01281 smoking former Smokers (>15 Years) never smokers 30872662 ES01282 fetal alcohol spectrum disorder (FASD) FASD cases healthy controls 30873861 ES01283 Parkinson's disease (PD) parkinson's disease patients healthy controls 30871403 ES01284 Parkinson's disease (PD) Parkinson's disease (PD) progression 30871403 ES01285 Parkinson's disease (PD) Parkinson's disease (PD) progression in PD cases receiving L-dopa/entacapone 30871403 ES01286 Parkinson's disease (PD) Parkinson's disease (PD) progression in PD cases NOT receiving L-dopa/entacapone 30871403 ES01287 pan-cancer cancer samples normal samples 31590287 ES01288 response to antidepressants responders non-responders 31594917 ES01289 response to methotrexate good response in rheumatoid arthritis poor response in rheumatoid arthritis 31598719 ES01290 polychlorinated biphenyls (PCBs) exposure PCB wet-weight concentrations 31607210 ES01291 gestational diabetes mellitus newborns exposed to GDM in utero healthy controls 31601636 ES01292 polycystic ovary syndrome (PCOS) women suffering from PCOS healthy controls 31600550 ES01293 smoking smoking status 31552803 ES01294 smoking cessation smoking cessation 31552803 ES01295 preterm birth small for gestational age appropriate for gestational age 31596135 ES01296 maternal smoking sustained maternal smoking during pregnancy children unexposed to maternal smoking 31536415 ES01297 smoking current smokers non-smokers 31536415 ES01298 type 2 diabetes (T2D) patients with incident Type 2 diabetes healthy controls 31506343 ES01299 colorectal cancer recurrent adenomas primary adenomas with recurrence 31334584 ES01300 colorectal cancer recurrent adenomas primary adenomas 31334584 ES01301 colorectal cancer colorectal adenomas normal mucosa samples 31334584 ES01302 colorectal cancer overall survival overall survival of colorectal cancer 31340858 ES01303 autistic trait scores on the Social and Communication Disorders Checklist (SCDC) 31346403 ES01304 renal clear cell carcinoma survival localized type 2 PRCC advanced?stage type 2 PRCC 31361072 ES01305 osteoarthritis (OA) Radiographic progressors Nonprogressors 31727952 ES01306 cervical cancer survival cervical cancer survival 31680300 ES01307 SETD1B-related syndrome patients with syndromic SETD1B-related diseases healthy controls 31685013 ES01308 hepatocellular carcinoma (HCC) hepatocellular cancer patients healthy controls 31695765 ES01309 asthma persistent asthma asthma in remission 31699840 ES01310 asthma asthma in remission healthy controls 31699840 ES01311 breastfeeding children with breastfeeding children without breastfeeding 31744183 ES01312 breastfeeding children with breastfeeding children without breastfeeding 31744183 ES01313 breastfeeding children with breastfeeding children without breastfeeding 31744183 ES01314 meditation practice after intensive meditation practice before intensive meditation practice 31733290 ES01315 metabolic syndrome (MetS) individuals with metabolic syndrome individuals without metabolic syndrome 31739726 ES01316 metabolic syndrome (MetS) individuals with metabolic syndrome individuals without metabolic syndrome 31739726 ES01317 aging aging 31739726 ES01318 aging aging 31739726 ES01319 poverty status poverty status 31739726 ES01320 poverty status poverty status 31739726 ES01321 gender male female 31739726 ES01322 gender male female 31739726 ES01323 panic disorder panic disorder patients healthy controls 31754096 ES01324 cisplatin treatment testicular cancer patients with cisplatin treatment testicular cancer patients without cisplatin treatment 31796056 ES01325 metabolic syndrome (MetS) testicular cancer patients with metabolic syndrome testicular cancer patients without metabolic syndrome 31796056 ES01326 papillary thyroid carcinoma differentiating differentiated thyroid cancer non?malignant follicular thyroid lesion 31797753 ES01327 invasiveness of pituitary adenoma invasive pituitary adenoma non-invasive pituitary adenoma 31796052 ES01328 hippocampus volume hippocampus volume 31811260 ES01329 esophageal cancer classification different subtypes of esophageal cancer 31834866 ES01330 sepsis septic critically ill patients nonseptic critically ill patients 31833902 ES01331 down syndrome Trisomy 21 patients healthy controls 31843015 ES01332 smoking (electronic cigarettes) smoking status(Never, E-cigs, Smokers) 31848205 ES01333 lung adenocarcinoma Tumor Normal 31850197 ES01334 gingivo-buccal oral squamous cell carcinoma (OSCC-GB) tumor tissues normal tissues 31796082 ES01335 preeclampsia preeclampsia patients healthy controls 31868881 ES01336 preeclampsia male-specific preeclampsia healthy controls 31868881 ES01337 cervical cancer cervical cancer patient healthy controls 31871774 ES01338 neonatal leptin neonatal leptin 31851703 ES01339 major depression disorder Development and Well-Being Assessment (DAWBA) depression band 31852353 ES01340 colon adenocarcinoma survival colon adenocarcinoma survival 31852837 ES01341 lung adenocarcinoma survival lung adenocarcinoma survival 31853300 ES01342 Attachment and Biobehavioral Catch-Up (ABC) Intervention ABC Intervention control intervention 31854285 ES01343 edematous severe acute childhood malnutrition (ESAM) ESAM non-edematous SAM 31857576 ES01344 paternal body mass index (BMI) paternal BMI 31880793 ES01345 paternal body mass index (BMI) paternal BMI (maternal BMI >= 25) 31880793 ES01346 maternal insulin sensitivity maternal insulin sensitivity (Matsuda index) 31882564 ES01347 maternal fatty acid concentrations preconceptional PUFAs concentrations 31858113 ES01348 maternal fatty acid concentrations preconceptional SFAs concentrations 31858113 ES01349 maternal fatty acid concentrations MUFAs concentrations at 8 weeks of gestation 31858113 ES01350 maternal fatty acid concentrations preconceptional trans FAs concentrations 31858113 ES01351 maternal fatty acid concentrations trans FAs concentrations at 8 weeks of gestation 31858113 ES01352 stages of cutaneous squamous cell carcinoma (cSCC) actinic keratosis, initial invasive carcinoma, high-risk non-metastatic carcinoma, metastatic carcinoma 31860637 ES01353 high risk cutaneous squamous cell carcinoma (cSCC) high risk cutaneous squamous cell carcinoma (cSCC) low risk cutaneous squamous cell carcinoma (cSCC) 31860637 ES01354 cutaneous squamous cell carcinoma (cSCC) survival cSCC survival 31860637 ES01355 colorectal cancer early diagnosis of colorectal cancer 31762318 ES01356 liver fat fraction at 10 years liver fat fraction at 10 years 31892367 ES01357 liver fat fraction at 10 years liver fat fraction at 10 years 31892367 ES01358 blood protein biomarker levels AHRR 31900413 ES01359 blood protein biomarker levels C4 31900413 ES01360 blood protein biomarker levels CLEC11A 31900413 ES01361 blood protein biomarker levels GP1BA 31900413 ES01362 blood protein biomarker levels ICAM5 31900413 ES01363 blood protein biomarker levels NLRC5 31900413 ES01364 blood protein biomarker levels PAPPA 31900413 ES01365 blood protein biomarker levels PRTN3 31900413 ES01366 blood protein biomarker levels SIGLEC5 31900413 ES01367 aging aging 31892350 ES01368 gender male female 31892350 ES01369 colorectal cancer colorectal cancer healthy controls 31894106 ES01370 colorectal cancer overall survival colorectal cancer overall survival 31894106 ES01371 colorectal cancer classification ctDNA-based molecular classification 31894106 ES01372 paternal smoking paternal smoking status 31827900 ES01373 melanoma classification primary non-lentiginous melanoma primary acral lentiginous melanoma 31888295 ES01374 melanoma classification metastatic acral lentiginous melanoma primary acral lentiginous melanoma and primary non-lentiginous melanoma 31888295 ES01375 melanoma classification metastatic acral lentiginous melanoma primary acral lentiginous melanoma 31888295 ES01376 melanoma melanoma acral nevus 31888295 ES01377 Alzheimer's disease (AD) Alzheimer’s disease healthy controls 31775875 ES01378 Alzheimer's disease (AD) AD dementia non-converters 31775875 ES01379 alcohol consumption alcohol intake 31789449 ES01380 alcohol consumption changes in alcohol consumption 31789449 ES01381 breast cancer breast cancer patitents healthy controls 31943067 ES01382 orofacial cleft orofacial cleft patients healthy control 30870065 ES01383 chemotherapy for breast cancer post-chemotherapy pre-chemotherapy 30867049 ES01384 breast cancer breast cancer patients healthy controls 30866861 ES01385 prenatal maternal antidepressants 30925934 ES01386 Gulf War Illness GWI patients healthy controls 30920300 ES01388 smoking Smokers Nonsmokers 30915882 ES01389 endotypes in difficult-to-control asthma cold hot 30915875 ES01390 early social deprivation children raised in orphanages children raised in biological families 30913238 ES01391 firefighter incumbent firefighter new recruit firefighters 30913233 ES01392 maternal radon exposure radon exposure 30906879 ES01393 Tetralogy of Fallot (TOF) cases of isolated TOF unaffected newborn 30977211 ES01394 birth weight birth weight 30966880 ES01395 gestational age gestational age 30966880 ES01397 maternal smoking maternal smoking status in pregnancy 30966880 ES01398 prenatal maternal metabolite levels prenatal maternal metabolite levels 30956810 ES01399 systemic sclerosis twins discordant for SSc 30947741 ES01400 limited cutaneous systemic sclerosis twin pairs discordant for lcSSc 30947741 ES01401 diffuse cutaneous systemic sclerosis twin pairs discordant for dcSSc 30947741 ES01402 hepatic fat hepatic fat 30936141 ES01403 lung function Forced expiratory volume in 1s (FEV1) 30935889 ES01404 lung function forced vital capacity (FVC) 30935889 ES01405 lung function FEV1/FVC 30935889 ES01406 chronic obstructive pulmonary disease (COPD) COPD patients healthy controls 30935889 ES01407 oestrogen receptor beta status in colorectal cancer ER? pos ER? neg 30931802 ES01408 neonatal neurobehavior NICU Network Neurobehavioral Scale (NNNS) profle classifcations 31004082 ES01409 systolic blood pressure systolic blood pressure 31999706 ES01410 diastolic blood pressure diastolic blood pressure 31999706 ES01411 hypertension hypertension patients healthy controls 31999706 ES01412 systolic blood pressure systolic blood pressure 31999706 ES01413 diastolic blood pressure diastolic blood pressure 31999706 ES01414 hypertension hypertension healthy controls 31999706 ES01415 systolic blood pressure systolic blood pressure 31999706 ES01416 diastolic blood pressure diastolic blood pressure 31999706 ES01417 hypertension hypertension patients healthy controls 31999706 ES01418 hepatocellular carcinoma overall survival hepatocellular carcinoma overall survival 31998802 ES01419 bullying exposure bullying exposure 31992121 ES01420 acute myelocytic leukemia (AML) survival acute myelocytic leukemia (AML) survival 31969992 ES01421 acute lymphocytic leukemia (ALL) survival acute lymphocytic leukemia (ALL) survival 31969992 ES01422 cervical cancer cervical cancer progress 31983058 ES01423 placental selenium (Se) levels placental selenium (Se) levels 32007686 ES01424 suicide attempt individuals with suicidal behavior individuals without suicidal behavior 32036075 ES01425 coeliac disease patients with coeliac disease healthy controls 32014011 ES01426 breast cancer prognosis tumor stage or treatment 32037691 ES01427 breast cancer prognosis tumor stage or treatment 32037691 ES01428 breast cancer prognosis tumor stage or treatment 32037691 ES01429 blood phosphatidylethanol level blood phosphatidylethanol level 32034291 ES01430 ischemic stroke ischemic stroke patients healthy controls 32202197 ES01431 down syndrome DS patients with complete T21 matched euploid donors 31915063 ES01432 seizure seizure before 18 months no seizure before 18 months 31915053 ES01433 seizure seizure since 7th birthday no seizure since 7th birthday 31915053 ES01434 seizure seizure since 9th birthday no seizure since 9th birthday 31915053 ES01435 seizure any seizures before age 13 no seizures before age 13 31915053 ES01436 alcohol consumption Ever user Never user 31910897 ES01437 smoking smoking status 31910897 ES01438 body mass index (BMI) BMI 31910897 ES01439 waist circumference (WC) WC 31910897 ES01440 blood lipids level blood lipids (TC, LDL-C, HDL-C, TG) 31910897 ES01441 blood C-reactive protein level blood C-reactive protein level 31910897 ES01442 aging aging 31910897 ES01443 renal clear cell carcinoma survival renal clear cell carcinoma survival 31926254 ES01444 severe sepsis septic critically ill patients nonseptic critically ill patients 31939781 ES01445 recurrent miscarriage patients with RM normal pregnant women 31938574 ES01446 recurrent miscarriage patients with RM healthy pregnant women 31938574 ES01447 childhood asthma subjects with asthma healthy controls 31932625 ES01448 childhood asthma subjects with asthma healthy controls 31932625 ES01449 childhood asthma subjects with asthma healthy controls 31932625 ES01450 post-traumatic stress disorder (PTSD) PTSD cases trauma exposed controls 31931860 ES01451 rhinitis rhinitis patients healthy controls 31953105 ES01452 asthma and/or rhinitis asthma and/or rhinitis patients healthy controls 31953105 ES01453 bariatric surgery post-bariatric surgery pre-bariatric surgery 31959221 ES01454 Alzheimer's disease with psychosis Alzheimer's disease with psychosis Alzheimer's disease without psychosis 32007278 ES01455 breast cancer invasiveness breast cancer invasiveness 32019269 ES01456 coarctation in neonates CoA 16 32019381 ES01457 stressful life event Life Events Questionnaire (LEQ) score 32048126 ES01458 perceived discrimination sum scores of the Everyday Discrimination Scale 32188935 ES01459 response to phylloquinone (vitamin K1) supplementation responders non-responders 32090699 ES01460 type 1 diabetes (T1D) T1D cases healthy controls 32111940 ES01463 inflamed Crohn's disease (CD) inflamed Crohn's disease patients non inflamed Crohn's disease patients 32251296 ES01464 Crohn's disease (CD) patients with CD healthy controls 32252817 ES01465 breast cancerization tumor ipsilateral-normal breast contralateral-normal tissue 32255732 ES01466 lung function FEV1/FVC 32264874 ES01467 inflammatory bowel disease inflammatory bowel disease patients healthy controls 32281463 ES01468 Alzheimer's disease (AD) AD patients healthy controls 32309439 ES01469 alcohol use disorder (AUD) AUD status 32398718 ES01470 obesity obese women normal-weight women 32404903 ES01471 short-term hypocaloric diet after diet before diet 32404903 ES01472 colorectal cancer overall survival colorectal cancer overall survival 32396412 ES01473 smoking current smokers never smokers 32395443 ES01474 smoking smokers non-smokers 32347401 ES01475 blood C-reactive protein level cord blood C-reactive protein levels 32354366 ES01476 non-atopic asthma non-atopic asthma healthy controls 32381493 ES01477 atopic asthma atopic asthma healthy controls 32381493 ES01478 cannabis exposure heavy cannabis users non-users 32321915 ES01479 adenoma adenoma healthy controls 32317010 ES01480 congenital adrenal hyperplasia congenital adrenal hyperplasia patients healthy controls 32428554 ES01481 infection?caused Leukocytopenia infection?caused Leukocytopenia healthy controls 32323775 ES01482 leukocytosis leukocytosis patients healthy controls 32323775 ES01483 KEAP1 mutations in lung adenocarcinoma KEAP1 mutations in lung adenocarcinoma KEAP1 wildtype in lung adenocarcinoma 32327612 ES01484 rheumatoid arthritis (RA) RA patients disease-discordant monozygotic twin 32292416 ES01485 obesity obese women normal weight women 32296077 ES01486 bariatric surgery after bariatric surgery before bariatric surgery 32296077 ES01487 maternal anxiety maternal anxiety at 36 weeks of gestation 32416664 ES01488 lung squamous cell carcinoma overall survival lung squamous cell carcinoma overall survival 32642165 ES01489 nongenital cutaneous warts epidermal samples of warts normal skin 32641122 ES01490 Dioxin-like compound exposure serum level of 28 dioxins, furans, and dioxin-like PCBs 32629249 ES01491 triple-negative breast cancer overall survival triple-negative breast cancer overall survival 32649035 ES01492 plantation work 10+ years plantation work exposure 0 years of plantation work 32650713 ES01493 plantation work 10+ years plantation work exposure 0 years of plantation work 32650713 ES01494 delayed cerebral ischemia after subarachnoid hemorrhage DCI patients healthy controls 32651463 ES01495 maternal plasma organochlorine pesticides concentrations maternal plasma organochlorine pesticides concentrations 32653021 ES01496 maternal plasma polychlorinated biphenyls concentrations Maternal PCB plasma concentration 32653021 ES01497 polychlorinated biphenyls (PCBs) exposure total PCB level 32660331 ES01498 suicide attempt in schizophrenia Suicidal ideators Non-suicidal ideators 32661777 ES01499 maternal lead exposure Blood spot Pb 32957503 ES01500 gallbladder cancer gallstone disease ? dysplasia ? GBC 33020926 ES01502 Papuan ancestry proportions 32453742 ES01503 attention-deficit/hyperactivity disorder (ADHD) 33184255 ES01504 smoking 32084330 ES01505 smoking smokers non-smokers 32731254 ES01506 attention-deficit/hyperactivity disorder (ADHD) 33184255 ES01507 smoking smokers non-smokers 32729352 ES01508 smoking smokers non-smokers 32729352 ES01509 multiple sclerosis multiple sclerosis-affected bronchoalveolar cells bronchoalveolar cells 32729352 ES01510 multiple sclerosis multiple sclerosis-affected bronchoalveolar cells bronchoalveolar cells 32729352 ES01511 breast cancer long-term survival 33194705 ES01512 weight loss 33198820 ES01513 colon cancer 33202377 ES01514 smoking smokers non-smokers 32745538 ES01515 smoking smokers Nonsmokers 32928150 ES01516 panic disorder 33208194 ES01517 ancestry European descent Chinese descent 33045984 ES01518 tissue sperm blood 33048947 ES01519 exercise after 6-week exercise training before 6-week exercise training 33052030 ES01520 child hunger exposed not exposed 33215951 ES01521 hepatocellular carcinoma (HCC) HCC tumor adjacent normal tissues (ANTs) 33059309 ES01522 muscle size and muscle strength Sarcopenic Non?sarcopenic 33058541 ES01523 Alzheimer's disease (AD) 33069246 ES01524 asthma children and adolescents with asthma children and adolescents without asthma 33093117 ES01525 atopic dermatitis atopic dermatitis patients healthy controls 33093567 ES01526 familial hypercholesterolemia FH mutation-negative hypercholesterolemia patients FH mutation-positive hypercholesterolemia patients 33096472 ES01527 target organ damage(TOD) target organ damage(TOD) matched normal 33100131 ES01528 nephritis nephritis non-nephritis 33108347 ES01529 ancestry African-American lupus patients European-American lupus patients 33108347 ES01530 breast cancer patients who developed a contralateral breast cancer patients who did not develop a contralateral breast cancer 33113958 ES01531 low birth weight NBW LBW 33070807 ES01532 breastfeeding 32443666 ES01533 chronic musculoskeletal pain Pain No pain 33073674 ES01534 serious neonatal morbidities 33076993 ES01535 ischemic stroke patients with hypertensive ischemic stroke healthy controls 33134510 ES01536 birth weight 32493484 ES01537 birth weight 33079621 ES01538 diabetic retinopathy 32493412 ES01539 pancreatic cancer risk pancreatic cancer healthy controls 33134824 ES01541 node?positive penile squamous cell carcinoma 33091959 ES01542 breastfeeding children with breastfeeding children without breastfeeding 33137917 ES01543 non-invasive sporadic breast cancer sporadic breast cancer healthy controls 33145876 ES01544 asthma asthmatic adolescents healthy adolescents 33150670 ES01545 a lifestyle intervention in pregnant women with obesity pregnant women with low glycaemic index diet plus physical activity pregnant women without low glycaemic index diet plus physical activity 33151971 ES01546 type 1 diabetes with develop diabetic kidney disease type 1 diabetes with develop diabetic kidney disease type 1 diabetes without develop diabetic kidney disease 33178681 ES01547 clear cell renal cell carcinoma clear cell renal cell carcinoma normal renal tissue 33178689 ES01548 age at Birth 32964196 ES01549 acoustic cry 32967004 ES01550 breast cancer 32970968 ES01551 prenatal PM 2.5 exposure 32971247 ES01552 systemic sclerosis 32977850 ES01553 ozone effects 32978449 ES01554 Kalahari KhoeSan individuals 32892676 ES01555 ameloblastoma ameloblastoma healthy controls 33022811 ES01557 depressive disorder depressive disorder healthy controls 32958748 ES01558 differentiation of skeletal muscle aged heterogenous muscle?derived human primary cells (HDMCs) young heterogenous muscle?derived human primary cells (HDMCs) ov 32958812 ES01559 HIV infection HIV-infected HIV-uninfected 32959881 ES01560 early-pregnancy blood glucose and insulin concentrations 32894192 ES01561 central adiposity 32901515 ES01562 autism spectrum disorders (ASD) ASD in South African children healthy controls 32490597 ES01563 central adiposity 32901515 ES01564 head and neck squamous cell carcinoma (HNSCC) head and neck squamous cell carcinoma (HNSCC) healthy controls 32961999 ES01565 head and neck squamous cell carcinoma (HNSCC) head and neck squamous cell carcinoma (HNSCC) oral lesions 32961999 ES01566 Maternal atopy 32902349 ES01567 Huntington’s disease 32913184 ES01568 endocrine disruptors 32916427 ES01569 chronic kidney disease related cardiovascular disease chronic kidney disease patients healthy donors 32930636 ES01570 Creutzfeldt–Jakob disease 32918118 ES01571 lung cancer 32762727 ES01572 prostate cancer 32764609 ES01573 major depression disorder major depression healthy controls 32843619 ES01574 Histological chorioamnionitis (HCA) Histological chorioamnionitis (HCA) healthy controls 32850550 ES01575 depression 32733030 ES01576 breast cancer 32733914 ES01577 maternal lead exposure 32734142 ES01578 gastric cardiac intestinal metaplasia 32736574 ES01579 first-onset schizophrenia first-onset schizophrenia patients healthy controls 32853717 ES01580 lung adenocarcinoma survival lung adenocarcinoma survival 32860318 ES01581 Alzheimer's disease (AD) AD patients normal control 32745807 ES01582 down syndrome down syndrome patients healthy controls 32861879 ES01583 Exposed to the World Trade Center Disaster WTC EHC NYUWHS 32751422 ES01584 maternal preconceptional and pregnancy micronutrient interventions maternal preconceptional and pregnancy micronutrient interventions non-exposure control 32889533 ES01585 birthweight 32754889 ES01586 HIV infection HIV-High HIV-Low 32760119 ES01587 hypospadias hypospadias healthy controls 32728162 ES01588 chordee chordee healthy controls 32728162 ES01589 severe hypospadias severe hypospadias cases 32728162 ES01590 non-small cell lung carcinoma (NSCLC) non-small cell lung carcinoma (NSCLC) healthy controls 32723974 ES01591 clear cell renal cell carcinoma clear cell renal cell carcinoma healthy controls 32832275 ES01592 preeclampsia preeclampsia patients healthy controls 32831145 ES01593 esophageal carcinoma esophageal carcinoma healthy controls 32830322 ES01594 interferon-? treatment for hepatosplenic T-cell lymphoma after interferon-? treatment for hepatosplenic T-cell lymphoma before interferon-? treatment for hepatosplenic T-cell lymphoma 32820235 ES01595 bladder cancer bladder cancer matched normal 32817589 ES01596 lung adenocarcinoma lung adenocarcinoma patients healthy controls 32805686 ES01597 allergic asthmatic children 32684341 ES01598 autism spectrum disorders (ASD) 32684367 ES01599 hepatocellular carcinomas 32685988 ES01600 lung adenocarcinoma 32688456 ES01601 asthma children with asthma healthy controls 32799603 ES01602 hepatocellular carcinoma (HCC) hepatocellular cancer patients adjacent non-tumor tissues 32793465 ES01603 Alzheimer's disease (AD) Alzheimer's disease patients healthy controls 32789163 ES01604 death risk 32697766 ES01605 obesity obesity healthy controls 32788176 ES01606 aging 32710526 ES01607 colorectal cancer susceptibility colorectal cancer patients healthy controls 32711505 ES01608 attention-deficit/hyperactivity disorder (ADHD) attention-deficit/hyperactivity disorder healthy controls 32561708 ES01609 bladder cancer survival bladder cancer 32565739 ES01610 prostate cancer prostate cancer matched normal 32576165 ES01611 Breast Cancer 32582547 ES01612 thoracic ossification of the ligamentum flavum 32583558 ES01614 Prenatal Depressive 32596638 ES01615 polybrominated biphenyl exposure of male polybrominated biphenyl exposure of male matched males 32496131 ES01616 polybrominated biphenyl exposure of female polybrominated biphenyl exposure of female female controls 32496131 ES01617 upper urinary tract urothelial carcinoma (UTUC) upper urinary tract urothelial carcinoma (UTUC) matched normal 32498593 ES01618 PBMC extract VEGF-A concentration PBMC extract VEGF-A concentration 32503626 ES01619 urinary Arsenic 32603190 ES01620 fibroblasts 32605309 ES01621 glaucoma 32606567 ES01622 osteoporosis 32496000 ES01623 blood pressure 32520614 ES01624 psoriasis 32522384 ES01625 cardiovascular disease risk 32525743 ES01626 soft tissue sarcoma survival soft tissue sarcoma survival 32508922 ES01627 lung adenocarcinoma 32530136 ES01628 hepatitis B virus (HBV)-related liver disease progression hepatitis B virus (HBV)-related liver disease progression 32513305 ES01629 temporal lobe epilepsy (TLE) temporal lobe epilepsy (TLE) matched normal 32519815 ES01630 drug response of temporal lobe epilepsy drug response of temporal lobe epilepsy 32519815 ES01631 smoking smokers non-smokers 32600451 ES01632 alcohol consumption alcohol consumption non-alcohol consumers 32600451 ES01633 oropharyngeal cancer survival oropharyngeal cancer survival 32600451 ES01634 neuroinflammation 32590150 ES01635 smoking smokers non-smokers 32583859 ES01636 aircraft day-evening-night noise aircraft day-evening-night noise 32484729 ES01637 railway day-evening-night noise railway day-evening-night noise 32484729 ES01638 road traffic day-evening-night noise road traffic day-evening-night noise 32484729 ES01639 air pollution (NO2) air pollution (NO2) 32484729 ES01640 air pollution (PM2.5) air pollution (PM2.5) 32484729 ES01641 Alzheimer's disease (AD) 32539856 ES01642 lung function 32541515 ES01643 osteosarcoma 33371144 ES01644 ovarian cancer ovarian cancer overall survival 33278864 ES01645 aging age 33276343 ES01647 gender gender 33276343 ES01648 vegan vegans non-vegetarians 33266012 ES01649 prenatal bisphenol A (BPA) exposure prenatal bisphenol A (BPA) exposure 33391824 ES01650 asthma remission complete remission persistent asthma 33303027 ES01651 asthma remission Clinical remission persistent asthma 33303027 ES01652 asthma remission complete remission persistent asthma 33303027 ES01653 asthma remission Clinical remission persistent asthma 33303027 ES01654 Alzheimer's disease (AD) 33257653 ES01655 APOE ?4 APOE ?4 carriers APOE ?2 carriers 33397400 ES01656 traumatic brain injury traumatic brain injury idiopathic normal pressure hydrocephalus 33401128 ES01657 Phelan-McDermid syndrome Phelan-McDermid syndrome 33407854 ES01658 ovarian cancer ovarian cancer(Monozygotic) healthy(Monozygotic) 33133257 ES01659 ovarian cancer ovarian cancer healthy 33133257 ES01660 nicotine metabolite cotinine Cotinine 33419350 ES01661 nicotine metabolite norcotinine norcotinine 33419350 ES01662 nicotine metabolite 3-Hydroxycotinine 3-Hydroxycotinine 33419350 ES01663 post-traumatic stress disorder (PTSD) post-traumatic stress disorder (PTSD) healthy controls 33235198 ES01664 hepatoblastoma Hepatoblastoma non-tumoral control liver sample 33256542 ES01665 diet quality 33354722 ES01666 colorectal cancer colorectal cancer healthy controls 32970347 ES01667 assisted reproduction technology (ART) assisted reproduction technology medically unassisted conceptions 33227132 ES01668 body mass index (BMI) 33239103 ES01669 body mass index (BMI) 33239103 ES01670 body mass index (BMI) 33239103 ES01671 body mass index (BMI) 33239103 ES01672 eosinophilic esophagitis response to topical steroids non-response to topical steroids 32986922 ES01673 early metastasis of uveal melanoma early metastasis of uveal melanoma no metastasis of uveal melanoma 33387485 ES01674 severe adolescent victimization severe adolescent victimization in the unpaired analysis 33371772 ES01675 severe adolescent victimization severe adolescent victimization in the unpaired analysis 33371772 ES01676 lung adenocarcinoma prognosis lung adenocarcinoma prognosis 33237038 ES01677 colorectal cancer prognosis colorectal cancer prognosis 33294438 ES01678 potential mediator between pigmentation genes, pigmentary traits and skin cancer potential mediator between pigmentation genes, pigmentary traits and skin cancer 33248005 ES01679 Alzheimer's disease (AD) Alzheimer's disease patients matched normal 33157432 ES01680 IgA nephropathy (IgAN) IgA nephropathy (IgAN) matched normal 33319642 ES01681 prostate cancer aggressive prostate tumors indolent prostate tumors 33420581 ES01682 cell-specific characterization of the placental methylome first trimester human placental samples term human placental samples 33407091 ES01683 maternal haemoglobin levels in pregnancy maternal haemoglobin levels in pregnancy 33331245 ES01684 smoking smokers non-smokers 33729499 ES01685 lung cancer lung cancer patients matched normal 33729499 ES01686 estimated glomerular filtration rate (eGFR) estimated glomerular filtration rate (eGFR) 33931109 ES01687 pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q) pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q) 33903952 ES01688 invasive lobular breast cancer overall survival invasive lobular breast cancer overall survival 33461604 ES01689 cardiovascular disease risk cardiovascular disease risk 33980183 ES01690 body mass index (BMI) body mass index (BMI) 33739972 ES01691 smoking smokers non-smokers 33739972 ES01692 smoking cessation former smokers never smokers 33593402 ES01693 smoking current smokers never smokers 33593402 ES01694 primary Sjögren's Syndrome (pSS) primary Sjögren’s Syndrome matched normal 33769968 ES01695 myelofibrosis risk myelofibrosis risk 33541399 ES01696 chronic lymphocytic leukemia 31919093 ES01697 oculo-auriculo-vertebral-spectrum oculo-auriculo-vertebral-spectrum patients matched normal 33530447 ES01698 preterm birth preterm samples matched normal 33886023 ES01699 body mass index (BMI) body mass index (BMI) 33810959 ES01700 body weight body weight 33810959 ES01701 hip-circumference hip-circumference 33810959 ES01702 body mass index (BMI) body mass index (BMI) 33766110 ES01703 fertility treatment fertility treatment no treatment 33823999 ES01704 OI/IUI OI/IUI no treatment 33823999 ES01705 glycemic response to glucagon- like peptide-1 analog therapy in type 2 diabetes mellitus glycemic response to glucagon- like peptide-1 analog therapy in type 2 diabetes mellitus 33674278 ES01706 glucose metabolism in type 1 diabetes after BCG vaccinations glucose metabolism in type 1 diabetes after BCG vaccinations 33933315 ES01708 exhaled carbon monoxide exhaled carbon monoxide 33567599 ES01709 end-stage kidney disease attributed to diabetic kidney disease end-stage kidney disease attributed to diabetic kidney disease 33933144 ES01710 clopidogrel resistance clopidogrel resistance 33519892 ES01711 hepatopulmonary syndrome hepatopulmonary syndrome patients matched normal 33630849 ES01712 diesel exhaust exposure diesel exhaust exposure 33859829 ES01713 binge-eating disorder binge-eating disorder 33922358 ES01714 paternal uniparental disomy paternal uniparental disomy 33513760 ES01715 COVID-19 Intensive care unit mild symptomatology 33867313 ES01716 COVID-19 Intensive care unit Hospitalization with O2 support 33867313 ES01717 COVID-19 Hospitalization with O2 support mild symptomatology 33867313 ES01718 aggressive behavior 33420481 ES01719 coffee consumption 33990564 ES01720 tea consumption 33990564 ES01721 blood high-density lipoprotein (HDL) levels 34183656 ES01722 blood high-density lipoprotein (HDL) levels 34183656 ES01723 blood low-density lipoprotein (LDL) levels 34183656 ES01724 blood triglyceride levels 34183656 ES01725 body mass index (BMI) 34670603 ES01726 waist circumference (WC) 34670603 ES01727 herbicide - dicamba 34516295 ES01728 herbicide - picloram 34516295 ES01729 herbicide - mesotrione 34516295 ES01730 herbicide - acetochlor 34516295 ES01731 herbicide - metolachlor 34516295 ES01732 herbicide - glyphosate 34516295 ES01733 herbicide - atrazine 34516295 ES01734 insecticide - heptachlor 34516295 ES01735 insecticide - malathion 34516295 ES01736 arsenic exposure exposed to arsenic non-exposure control 34243768 ES01737 arsenic exposure arsenic exposure non-exposure control 34243768 ES01738 carotid intima-media thickness 34091768 ES01739 maternal depression 34750344 ES01740 air pollution (PM2.5) 34717175 ES01741 air pollution (black carbon) 34717175 ES01742 air pollution (Cu) 34717175 ES01743 air pollution (Pb) 34717175 ES01744 air pollution (Zn) 34717175 ES01745 air pollution (Ni) 34717175 ES01746 air pollution (V) 34717175 ES01747 air pollution (Ca) 34717175 ES01748 air pollution (Fe) 34717175 ES01749 air pollution (Al) 34717175 ES01750 air pollution (Si) 34717175 ES01751 air pollution (K) 34717175 ES01752 air pollution (S) 34717175 ES01753 air pollution (Na) 34717175 ES01754 cognitive function (processing speed) 33883019 ES01755 cognitive function (spatial ability) 33883019 ES01756 cognitive function (working memory) 33883019 ES01757 global cortical volumes (cerebral white matter) 34738878 ES01758 global cortical volumes (total grey matter ) 34738878 ES01759 global cortical volumes (whole brain volume) 34738878 ES01760 waist circumference (WC) 34556110 ES01761 traumatic brain injury traumatic brain injury idiopathic normal pressure hydrocephalus 33191850 ES01762 lung function 33748261 ES01763 di-2-ethylhexyl phthalate exposure 33872906 ES01764 autism spectrum disorders (ASD) autism 34404318 ES01765 maternal depression comorbid with anxiety 33845866 ES01766 braak stage 34112773 ES01767 Alzheimer's disease (AD) - CDR-SB 34654479 ES01768 birth weight 33741061 ES01769 small for gestational age adequate for gestational age small for gestational age 33741061 ES01770 Alzheimer's disease (AD) - sex stratified 33902726 ES01771 Alzheimer's disease (AD) - sex stratified 33902726 ES01772 infant sex Female Male 34569420 ES01773 infant sex Female Male 34569420 ES01774 infant sex Female Male 34569420 ES01775 infant sex Female Male 34569420 ES01776 malignant pleural mesothelioma malignant pleural mesothelioma cancer-free controls 34071989 ES01777 abdominal radiotherapy treatment abdominal radiotherapy treatment control 33823916 ES01778 brain radiotherapy treatment brain radiotherapy treatment control 33823916 ES01779 abdominal radiotherapy treatment abdominal radiotherapy treatment control 33823916 ES01780 brain radiotherapy treatment brain radiotherapy treatment control 33823916 ES01781 corticosteroids treatment corticosteroids treatment control 33823916 ES01782 non-stroke cardiovascular disease 34167563 ES01783 overall stroke cardiovascular disease 34167563 ES01784 ischemic stroke cardiovascular disease 34167563 ES01785 Pb exposure 33940396 ES01786 body mass index (BMI) 34207686 ES01787 aging 34427971 ES01788 exposure to violence or chronic stress 33751861 ES01789 gestational diabetes mellitus gestational diabetes mellitus (GDM) control 34104645 ES01790 prenatal risk physical risk typical 34507616 ES01791 prenatal risk psychological risk typical 34507616 ES01792 prenatal risk Cumulative Prenatal Risk 34507616 ES01793 periodontitis periodontitis cases clinically uninflamed 34732256 ES01794 preterm birth 34482817 ES01795 polybrominated diphenyl ethers 34425644 ES01796 newborn birthweight with maternal smoking 33663600 ES01797 lung cancer risk 34008478 ES01798 Tic spectrum disorder 34680906 ES01799 adverse childhood experience 34333774 ES01800 gestational diabetes mellitus 34174944 ES01801 prenatal exposure to endocrine disrupting chemicals 34529553 ES01802 sex male female 34732242 ES01803 HDA plasma level 34335698 ES01804 HDA urine level 34335698 ES01805 TAHI plasma level 34335698 ES01806 TAHI urine level 34335698 ES01807 infancy with toddler attachment style 34196256 ES01808 fasting plasma glucose 34328084 ES01809 treated with assisted reproductive technology IVF ICSI 33890633 ES01810 assisted reproduction technology (ART) assisted reproduction technology conceived singleton newborns naturally conceived singleton newborns 35393427 ES01811 prostate cancer aggressive prostate tumors indolent prostate tumors 35053153 ES01812 preeclampsia Pregnant women with pre-eclampsia Pregnant women without preeclampsia 34930449 ES01813 maternal hypertensive disorders in pregnancy Pregnant women with gestational hypertension Pregnant women without gestational hypertension 34930449 ES01814 colorectal cancer colorectal cancer patients adjacent normal tissues 35054365 ES01815 low carbohydrate diet people on low carbohydrate diet people on normal carbohydrate diet 34736535 ES01816 exercise plus carbohydrate diet exercise plus carbohydrate diet controls 34736535 ES01817 smoking ever smoker never smoker 34789321 ES01818 smoking cessation current smokers former smokers 34789321 ES01819 kidney renal clear cell carcinoma kidney renal clear cell carcinoma matched adjacent normal tissue 34984182 ES01820 kidney renal papillary cell carcinoma kidney renal papillary cell carcinoma matched adjacent normal tissue 34984182 ES01821 autoimmune thyroiditis patients with autoimmune thyroiditis healthy controls 34382413 ES01822 lung function (forced expiratory volume the first second, FEV1) lung function (forced expiratory volume the first second, FEV1) 35536696 ES01823 lung function (forced vital capacity,FVC) lung function (forced vital capacity, FVC) 35536696 ES01824 lung function (FEV1/FVC) lung function (FEV1/FVC) 35536696 ES01825 mortality mortality risk score 34808433 ES01826 post-traumatic stress disorder (PTSD) associated with rape women with PTSD at 3-months post-rape women without PTSD at 3-months post-rape 34799556 ES01860 anorexia nervosa patients with anorexia nervosa healthy controls 35013117 ES01861 hutchinson gilford progeria syndrome (HGPS) progeroid laminopathy patients controls 35045206 ES01862 air pollution (PM2.5) PM2.5 exposure groups groups not exposed to PM2.5 34964497 ES01863 long-term air pollution exposure levels (NOx) NOx exposure groups groups not exposed to NOx 34964497 ES01864 ischemic moyamoya disease (MMD) groups with ischemic moyamoya disease groups without ischemic moyamoya disease 35368875 ES01865 maternal PM10 exposure in third trimester PM10 concentration 35063426 ES01866 maternal PM10 exposure in third gestational week PM10 concentration 35063426 ES01867 maternal PM10 exposure in second gestational week PM10 concentration 35063426 ES01868 maternal PM10 exposure in fifth gestational week PM10 concentration 35063426 ES01869 maternal PM10 exposure in first trimester PM10 concentration 35063426 ES01870 maternal PM10 exposure in fourth gestational week PM10 concentration 35063426 ES01871 maternal PM10 exposure in the last month PM10 concentration 35063426 ES01872 maternal PM10 exposure in the first month PM10 concentration 35063426 ES01873 maternal PM10 exposure in pregnancy PM10 concentration 35063426 ES01874 past-month post-traumatic stress disorder (PTSD) PTSD cases normal controls 35177594 ES01875 lifetime past-month post-traumatic stress disorder (PTSD) PTSD cases normal controls 35177594 ES01876 lifestyle scores (LS) people with healthy lifestyle people with unhealthy lifestyle 35692099 ES01877 prenatal perfluorooctanoate (PFOA) exposure perfluorooctanoate (PFOA) levels in maternal serum 35266797 ES01878 prenatal perfluorooctane sulfonate (PFOS) exposure perfluorooctane sulfonate (PFOS) levels in maternal serum 35266797 ES01879 prenatal perfluorohexane sulfonate (PFHxS) exposure perfluorohexane sulfonate (PFHxS) levels in maternal serum 35266797 ES01880 prenatal perfluorononanoate (PFNA) exposure prenatal perfluorononanoate (PFNA) levels in maternal serum 35266797 ES01881 triiodothyronine (T3) treatment human monocytes in vitro treated by Triiodothyronine (T3) human monocytes in vitro treated by RPMI 35327410 ES01882 colorectal cancer colorectal cancerous tissues colorectal adjacent normal tissues 35127488 ES01883 type 2 diabetes (T2D) incident type 2 diabetes matched normal 35169870 ES01884 air pollution exposure levels (NOx) during pregnancy air pollution exposure levels (NOx) during pregnancy 34941772 ES01885 breast cancer risk breast cancer risk 34411412 ES01886 salivary gland pleomorphic adenomas growth rate fast-growing salivary gland pleomorphic adenomas slow-growing salivary gland pleomorphic adenomas 35682648 ES01887 mediterranean diet during pregnancy women adhering to a Mediterranean diet during pregnancy woman on non-Mediterranean diet during pregnancy 35236238 ES01888 sleep midpoint during pregnancy sleep midpoint during pregnancy 35596190 ES01889 gender affirming hormone therapy (GAHT) of transgender women transgender women after feminizing GAHT 6-month or 12-month transgender women before feminizing GAHT 6-month or 12-month 35177097 ES01890 8 weeks of supervised exercise training after 8 weeks of supervised exercise training before 8 weeks of supervised exercise training 35323665 ES01891 acupuncture treatment for patients with burnout patient with burnout after acupuncture patient with burnout before acupuncture 34875647 ES01892 ischemic stroke ischemic stroke patients matched normal 35480311 ES01893 aging 35489615 ES01895 typical meningiomas deterioration dismal patients with atypical meningiomas benign patients with atypical meningiomas 35356207 ES01896 birthweight birth weight (g) 33784941 ES01897 suicide attempt in schizophrenia suicidal ideators non-suicidal ideators 35627945 ES01898 primary sclerosing cholangitis - ulcerative colitis (PSC-UC) primary sclerosing cholangitis - ulcerative colitis (PSC-UC) ulcerative colitis (UC) 35371111 ES01899 Bohring-Opitz syndrome (BOS) individuals carrying LOF variants in ASXL1 and a clinical diagnosis of Bohring-Opitz syndrome (BOS) developing controls 35361921 ES01900 folic acid supplement during pregnancy 400 µg/day folic acid supplement during pregnancy matched controls 35578268 ES01901 identify lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) lung adenocarcinoma (LUAD) lung squamous cell carcinoma (LUSC) 35280307 ES01902 lung adenocarcinoma lung adenocarcinoma matched normal 35280307 ES01903 lung squamous cell carcinoma lung squamous cell carcinoma matched normal 35280307 ES01904 childhood aeroallergen sensitization risk childhood aeroallergen sensitization risk 35437756 ES01905 educational attainment determinant of health among survivors of childhood cancer educational attainment determinant of health among survivors of childhood cancer 35109748 ES01906 antidepressant use antidepressant use sample matched controls 34880450 ES01908 early-life adversity in youth youths with early-life adversity youths without early-life adversity 35395780 ES01909 difference between monocytic cells and granulocytic cells monocytic cells of adult blood granulocytic cells of adult blood 35189960 ES01910 pet ownership in pregnancy mothers who owned pets during pregnancy mothers who did not own pets during pregnancy 34642452 ES01911 stroke outcome stroke outcome 36180927 ES01912 smoking smokers non-smokers 36834337 ES01913 cancer testis antigens in colorectal cancer cancer tissues of colorectal cancer the corresponding adjacent normal tissues of colorectal cancer 36932973 ES01914 prenatal social support in low-risk pregnancy degree of social support 36617561 ES01915 oral squamous cell carcinoma (OSCC) with proliferative verrucous leukoplakia (PVL) oral squamous cell carcinoma (OSCC) with proliferative verrucous leukoplakia (PVL) oral squamous cell carcinoma (OSCC) without proliferative verrucous leukoplakia (PVL) 36892444 ES01916 amyotrophic lateral sclerosis amyotrophic lateral sclerosis monozygotic twins matched normal monozygotic twins 37152709 ES01917 gastric cardia cancer gastric cardia cancer adjacent normal tissues 36342849 ES01918 type 2 diabetes (T2D) incident type 2 diabetes matched normal 35947335 ES01919 triglycerides concentration in plasma 36791658 ES01920 body mass index (BMI) body mass index (BMI) 36479596 ES01921 hydroxytyrosol treatment in Caco-2 cells different concentrations of hydroxytyrosol treatment in Caco-2 cells 36528246 ES01922 cognitive impairment in Mexican American cognitive impairment patients normal controls 36872777 ES01923 cognitive impairment in non-Hispanic whites cognitive impairment patients normal controls 36872777 ES01924 hypertension hypertension patients controls 36172862 ES01925 frozen embryo transfer frozen embryo transfer fresh embryo transfer 35717573 ES01926 blood triglyceride levels blood triglyceride levels 36274151 ES01927 blood triglyceride levels blood triglyceride levels 36274151 ES01928 blood total cholesterol levels blood total cholesterol levels 36274151 ES01929 blood total cholesterol levels blood total cholesterol levels 36274151 ES01930 blood low density lipoprotein (LDL) levels blood low density lipoprotein (LDL) levels 36274151 ES01931 blood low density lipoprotein (LDL) levels blood low density lipoprotein (LDL) levels 36274151 ES01932 serum albumin levels serum albumin levels 36303554 ES01933 maternal-fetal stress maternal-fetal stress level 35836289 ES01934 maternal-fetal stress maternal-fetal stress level 35836289 ES01935 maternal-fetal stress maternal-fetal stress level 35836289 ES01936 maternal-fetal stress maternal-fetal stress level 35836289 ES01937 renin renin level 36457109 ES01938 aldosterone aldosterone level 36457109 ES01939 aldosterone-to-renin ratio (ARR) aldosterone-to-renin ratio (ARR) 36457109 ES01940 large for gestational age (LGA) large for gestational age (LGA) optimal for gestational age 36585686 ES01941 mitotic index mitotic index 36551712 ES01942 birthweight birthweight 36457128 ES01943 birthweight birthweight 36457128 ES01944 antenatal care plus healthy lifestyle participants with antenatal care plus healthy lifestyle participants without intervention 36137169 ES01945 lung squamous cell carcinoma lung squamous cell carcinoma normal control 36142605 ES01946 metastatic luminal B breast cancer metastatic luminal B breast cancer normal controls 36393855 ES01947 Mongolians Mongolian adults Thai adults 35986394 ES01948 habitual daily food consumption dietary intake of food groups and nutrients 35888152 ES01949 recurrent adult-type IDH-mutant gliomas recurrent adult-type IDH-mutant gliomas primary adult-type IDH-mutant gliomas 36739454 ES01950 pediatric acute lymphoblastic leukemia pediatric acute lymphoblastic leukemia in monozygotic twins normal control in monozygotic twins 36241624 ES01951 childhood environment adults exposed to different levels of SES, discrimination, family harshness, community danger in childhood 34533092 ES01952 rheumatoid arthritis (RA) rheumatoid arthritis patients osteoarthritis patients 36273177 ES01953 endoscopic post-operative recurrence in Crohn’s disease Crohn’s disease patients presenting severe recurrence Crohn’s disease patients presenting clear endoscopic remission 36142381 ES01954 a lifestyle intervention in pregnant women women with lifestyle interventions during pregnancy women without lifestyle interventions during pregnancy 35749371 ES01955 a lifestyle intervention in pregnant women women with lifestyle interventions during pregnancy women without lifestyle interventions during pregnancy 35749371 ES01956 maternal BMI maternal BMI 35749371 ES01957 cutaneous melanoma cutaneous melanoma matched cancer-free controls 35987900 ES01958 sickle cell disease (SCD) with HbSS genotype pregnancies with sickle cell disease (HbSS genotype) control pregnancies 36129958 ES01959 sickle cell disease (SCD) with HbSC genotype pregnancies with sickle cell disease (HbSC genotype) control pregnancies 36129958 ES01960 maternal trypanosoma cruzi infection exposure maternal trypanosoma cruzi infection exposure no maternal exposure to trypanosoma cruzi infection 36039408 ES01961 systemic lupus erythematosus (SLE) subtypes patients with systemic lupus erythematosus 35635730 ES01962 maternal type 1 diabetes (T1DM) adolescent offspring born to women with T1DM adolescent offspring born to women without T1DM 36138412 ES01963 familial prostate cancer risk multiple-case prostate cancer families, including prostate cancer cases multiple-case prostate cancer families, without prostate cancer 36708485 ES01964 preclinical malignant pleural mesothelioma (MPM) malignant pleural mesothelioma matched normal 36305648 ES01965 suicide attempt individuals with high-risk suicidal attempt individuals with low-risk suicidal attempt 36857986 ES01966 self-esteem (SE) participants with low self-esteem participants with normal self-esteem 37152987 ES01967 emotionally unstable personality disorder (EUPD) women with emotionally unstable personality disorder (EUPD) with at least two serious suicide attempts (SAs) healthy female controls 36766691 ES01968 blood C-reactive protein level blood C-reactive protein level 35504910 ES01969 clonal hematopoiesis of indeterminate potential clonal hematopoiesis of indeterminate potential 36097025 ES01970 white matter hyperintensities white matter hyperintensities 35943854 ES01971 persistant cocaine use participants with persistent cocaine use participants without cocaine use 32928285 ES01972 HIV severity HIV severity 32928285 ES01973 menstrual cycle phases menstrual cycle phases 37587191 ES01974 diabetic chronic kidney disease progression individuals with diabetic chronic kidney disease progression individuals with diabetic chronic kidney disease non-progression 37210443 ES01975 pancreatic cancer pancreatic cancer patients healthy controls 35030986 ES01976 pancreatic cancer pancreatic cancer patients healthy controls 35030986 ES01977 body mass index (BMI) BMI 30638414 ES01978 recurrence risk of early-onset endometrioid endometrial cancer patients with low-recurrence-risk early-onset endometrioid endometrial cancer patients with high-recurrence-risk early-onset endometrioid endometrial cancer 36047377 ES01979 recurrence risk of early-onset endometrioid endometrial cancer patients with low-recurrence-risk early-onset endometrioid endometrial cancer patients with high-recurrence-risk early-onset endometrioid endometrial cancer 36047377 ES01980 early-onset endometrial cancer patients with early-onset endometrial cancer (age <= 40 years) patients with late-onset endometrial cancer (age > 40 years) 30850842 ES01981 ulcerative colitis children with ulcerative colitis children without ulcerative colitis 36964596 ES01983 invasive tumor front of aggressive uterine adenocarcinoma invasive tumor front of aggressive uterine adenocarcinoma 36467415 ES01984 invasive tumor front of uterine leiomyosarcoma invasive tumor front of uterine leiomyosarcoma 36467415 ES01985 konzo disease individuals with konzo disease individuals without konzo disease 36536449 ES01986 epithelial mesenchymal transition in non-small cell lung cancer HCC827 cells HCC827EMT cell clones HCC827PAR cells 36762066 ES01987 lean mass lean mass in postmenopausal women 37123284 ES01988 selective P2RY1 receptor agonist MRS2365 treatment in diffuse gastric cancer diffuse gastric cancer treated selective P2RY1 receptor agonist MRS2365by matched normal tissue treated selective P2RY1 receptor agonist MRS2365 36879646 ES01989 KBG syndrome individuals with KBGS and pathogenic variants in ANKRD11 typically developing controls 36440975 ES01990 Crohn's disease (CD) Crohn’s disease patients ulcerative colitis (UC) 36581079 ES01991 assisted reproduction technology (ART) new-born girls with assisted reproduction technology new-born girls without assisted reproduction technology 37085889 ES01992 assisted reproduction technology (ART) new-born boys with assisted reproduction technology new-born boys without assisted reproduction technology 37085889 ES01993 aerobic training for breast cancer after aerobic-training intervention before aerobic-training intervention 36542473 ES01994 aerobic training for healthy people after aerobic-training intervention before aerobic-training intervention 36542473 ES01995 antidepressant response responders with depressive disorder treated for 8 weeks non-responders with depressive disorder treated for 8 weeks 37186582 ES01996 inflammatory bowel disease (IBD) patients with inflammatory bowel disease healthy controls 36029471 ES01999 ulcerative colitis (UC) individuals with ulcerative colitis healthy controls 36029471 ES02000 Crohn's disease (CD) CD patients healthy controls 36029471 ES02001 hypertrophic cardiomyopathy (HCM) individuals with hypertrophic cardiomyopathy individuals with aortic stenosis 36499607 ES02002 obesity overweight or obesity individuals with daily caloric restriction overweight or obesity individuals with intermittent fasting 37630778 ES02003 maternal pre-pregnancy obesity newborns in mother–child pairs mothers in mother–child pairs 37612641 ES02004 gestational diabetes pregnant women with gestational diabetes mellitus 16 non-gestational diabetes mellitus 37192269 ES02005 anthracycline-induced cardiomyopathy anthracycline-exposed childhood cancer survivors with cardiomyopathy survivors with no cardiomyopathy 37542143 ES02006 response to tofacitinib in moderate-to-severe ulcerative colitis responders non-responders 37526299 ES02007 sexually dimorphic male female 37608375 ES02008 lupus nephritis patients with lupus nephritis control group 37506491 ES02009 steroidogenesis biosynthesis paediatric intensive care unit patients at 2-year follow-up healthy children with comparable sex and age 37468957 ES02010 maternal caffeine consumption self-reported caffeine intake 38018434 ES02011 sexually dimorphic male female 37608375 ES02012 metabolic syndrome (MetS) metabolic syndrome healthy controls 34780523 ES02013 metabolic syndrome (MetS) metabolic syndrome healthy controls 34780523 ES02014 ischemic stroke ischemic stroke patients healthy controls 37370144 ES02015 ischemic stroke ischemic stroke patients healthy controls 37370144 ES02016 pubertal development scale(PDS) 12 pubertal development scale(PDS) 12 37950287 ES02017 pubertal development scale (PDS) pubertal development scale (PDS) 37950287 ES02018 pubertal development scale (PDS) pubertal development scale (PDS) 37950287 ES02019 pubertal age (PA) pubertal age (PA) 37950287 ES02020 pubertal age (PA) pubertal age (PA) 37950287 ES02021 exposed to COVID-19 during pregnancy infants exposed to COVID-19 during pregnancy control infants with no COVID-19 exposure 37425024 ES02022 gastric cardiac type 1 intestinal metaplasia individuals with gastric cardiac type 1 intestinal metaplasia individuals without gastric cardiac type 1 intestinal metaplasia 38258659 ES02023 gastric cardiac type 2 intestinal metaplasia individuals with gastric cardiac type 2 intestinal metaplasia individuals without gastric cardiac type 2 intestinal metaplasia 38258659 ES02024 gastric cardiac type 3 intestinal metaplasia individuals with gastric cardiac type 3 intestinal metaplasia individuals without gastric cardiac type 3 intestinal metaplasia 38258659 ES02025 gastric cardiac intraepithelial neoplasia individuals with gastric cardiac intraepithelial neoplasia individuals without gastric cardiac intraepithelial neoplasia 38258659 ES02029 stroke prognosis patients with poor stroke outcome 38845005 ES02030 stroke prognosis patients with poor stroke outcome 38845005 ES02031 smoking current smokers never smokers 38199042 ES02032 treatment-resistant depression?TRD? treatment-resistant depression?TRD? patients treated with trauma-focused psychotherapy?TFP? 38362742 ES02033 Lyme neuroborreliosis (LNB) patients with Lyme neuroborreliosis (LNB) patients without Lyme neuroborreliosis (LNB) 37824827 ES02034 type 1 diabetes (T1D) with proliferative diabetic retinopathy (PDR) proliferative diabetic retinopathy (PDR) over 28 years 38601260 ES02035 blood C-reactive protein level blood C-reactive protein level 38571307 ES02036 type 2 diabetes (T2D) individuals with T2D individuals without T2D 37679740 ES02037 type 2 diabetes (T2D) individuals with T2D individuals without T2D 37679740 ES02038 height height 37626025 ES02039 height height 37626025 ES02040 persistant cocaine use frequency of cocaine use 37730558 ES02041 persistant cocaine use frequency of cocaine use 37730558 ES02042 blood C-reactive protein level blood C-reactive protein level 38571307 ES02043 serum immunoglobulin E (IgE) levels serum immunoglobulin E (IgE) levels 37598461 ES02044 diet quality diet score 37793095 ES02045 metabolic syndrome (MetS) individuals with metabolic syndrome 38685121 ES02046 diet quality diet score 37793095 ES02047 diet quality diet score 37793095 ES02048 metabolic syndrome (MetS) individuals with metabolic syndrome 38685121 ES02049 metabolic syndrome (MetS) individuals with metabolic syndrome 38685121 ES02050 metabolic syndrome (MetS) 38419113 ES02051 free thyroxine 4 free thyroxine 4 level 36719767 ES02052 free thyroxine 3 free thyroxine 3 level 36719767 ES02053 free thyroxine 3 free thyroxine 3 level 36719767 ES02054 free thyroxine 4 free thyroxine 4 level 36719767 ES02055 systolic blood pressure systolic blood pressure 32917208 ES02056 diastolic blood pressure diastolic blood pressure 32917208 ES02059 transformed thyrotropin transformed thyrotropin level 36719767 ES02060 colon cancer 38188020 ES02061 Pitt-Hopkins syndrome (PTHS) Pitt-Hopkins syndrome (PTHS) 38571311 ES02062 Normalized Difference Vegetation Index (NDVI) 100m NDVI 100m 38776651 ES02064 Koolen-de Vries syndrome (KdVS) participants with Koolen-de Vries syndrome participants without Koolen-de Vries syndrome 38282074 ES02065 Normalized Difference Vegetation Index (NDVI) 100m NDVI 100m 38776651 ES02066 Normalized Difference Vegetation Index (NDVI) 100m NDVI 100m 38776651 ES02067 Koolen-de Vries syndrome (KdVS) participants with Koolen-de Vries syndrome participants without Koolen-de Vries syndrome 38282074 ES02068 Normalized Difference Vegetation Index (NDVI) 300m NDVI 300m 38776651 ES02069 Normalized Difference Vegetation Index (NDVI) 300m NDVI 300m 38776651 ES02070 Normalized Difference Vegetation Index (NDVI) 300m NDVI 300m 38776651 ES02071 Green proximity Green proximity 38776651 ES02072 Green proximity Green proximity 38776651 ES02073 Normalized Difference Vegetation Index (NDVI) 100m NDVI 100m 38776651 ES02074 Normalized Difference Vegetation Index (NDVI) 300m NDVI 300m 38776651 ES02075 nasopharyngeal carcinoma healthy cancer 38086861 ES02076 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02077 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02078 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02079 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02080 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02081 Alzheimer's disease (AD) traffic?related PM2.5 38345197 ES02082 breast tumours IL21R hypomethylation 38723244 ES02083 kidney disease cardiovascular death 37207321 ES02084 colorectal cancer colorectal cancer patients 37964634 ES02085 papillary thyroid cancer papillary thyroid cancer benign thyroid nodules 38126720 ES02086 Proliferative verrucous leukoplakia (PVL) Proliferative verrucous leukoplakia (PVL) homogeneous leucoplakia (HL) 38852153 ES02087 Sex-specific DNA methylation female male 37300819 ES02088 Sex-specific DNA methylation female male 37300819 ES02089 respiratory allergies (RA) aspirin-exacerbated respiratory disease aspirin-tolerant asthma 38386995 ES02090 Pancreatic ductal adenocarcinoma (PDAC) Pancreatic ductal adenocarcinoma (PDAC) healthy controls 38853072 ES02091 sex hormone 10 years later before 10 years 36994855 ES02092 night shift work intermediate term night shift workers non-shift workers 36457290 ES02093 night shift work intermediate term night shift workers short-term night shift workers 36457290 ES02094 night shift work short-term night shift workers non-shift workers 36457290 ES02095 night shift work short-term night shift workers non-shift workers 36457290 ES02096 night shift work intermediate term night shift workers non-shift workers 36457290 ES02097 night shift work intermediate term night shift workers short-term night shift workers 36457290 ES02098 racialized and economic inequities, and air pollution Light Absorption Coefficient 38105971 ES02099 racialized and economic inequities, and air pollution Nitrogen oxides 38105971 ES02100 Detailed DNA methylation characterisation of phyllodes tumours phyllodes tumours breast carcinoma 38300122 ES02101 severe clinical phenotypes of septic patients Septic shock patients critically ill patients 38235139 ES02102 severe clinical phenotypes of septic patients Sepsis patients critically ill patients 38235139 ES02103 severe clinical phenotypes of septic patients septic shock patients Sepsis patients 38235139 ES02105 early gastric cancer non-tumors tumors 38507065 ES02114 Alzheimer’s Disease Alzheimer’s Disease 38564759 ES02115 current smoking current smoking 38927065 ES02118 former smoking former smoking 38927065 ES02119 genetic variation genetic variation 38449836 ES02123 Chung-Jansen syndrome Chung-Jansen syndrome 38787418 ES02124 Chung-Jansen syndrome Chung-Jansen syndrome 38787418 ES02125 COVID-19 SARS-CoV-2 RT-PCR severe positive individuals SARS-CoV-2 RT-PCR negative individuals 35933486 ES02126 COVID-19 SARS-CoV-2 RT-PCR mild positive individuals SARS-CoV-2 RT-PCR negative individuals 35933486 ES02127 COVID-19 severity SARS-CoV-2 RT-PCR severe positive individuals SARS-CoV-2 RT-PCR mild positive individuals 35933486 ES02128 COVID-19 COVID?19 positive patients COVID?19 negtive controls 34185889 ES02129 general cognitive functions childhood general cognitive score 39304652 ES02130 chronological age 39118140 ES02131 the body mass index (BMI) of children 38986426 ES02132 multiple system atrophy multiple system atrophy neurologically healthy controls 38995454 ES02133 Parkinson's disease (PD) Parkinson’s disease neurologically healthy controls 38995454 ES02134 progressive supranuclear palsy progressive supranuclear palsy neurologically healthy controls 38995454 ES02135 multiple system atrophy multiple system atrophy Parkinson’s disease 38995454 ES02136 multiple system atrophy multiple system atrophy progressive supranuclear palsy 38995454 ES02137 Parkinson’s disease Parkinson’s disease progressive supranuclear palsy 38995454 ES02138 Alzheimer's disease (AD) Alzheimer's disease (AD) mild cognitive impairment (MCI) 39193893 ES02139 depression depressed individuals healthy controls 39062924 ES02140 alcohol use disorder (AUD) AUD no lifetime history of AUD symptoms 39399155 ES02141 alcohol use disorder (AUD) AUD no lifetime history of AUD symptoms 39399155 ES02142 prenatal EDC exposure 38972116 ES02143 prenatal EDC exposure 38972116 ES02144 prenatal EDC exposure 38972116 ES02145 metabolic dysfunction-associated steatotic liver disease (MASLD) MASLD healthy controls 39334355 ES02146 metabolic dysfunction-associated steatotic liver disease (MASLD) MASLD healthy controls 39334355 ES02147 metabolic dysfunction-associated steatotic liver disease (MASLD) MASLD healthy controls 39334355 ES02148 autoimmune thyroiditis AIT healthy controls 39401997 ES02149 smoking smokers never smokers 39425209 ES02150 bariatric surgery after bariatric surgery before bariatric surgery 39002385 ES02151 bariatric surgery after bariatric surgery before bariatric surgery 39002385 ES02152 bariatric surgery after bariatric surgery before bariatric surgery 39002385 ES02153 asthma 39488688 ES02154 asthma 39488688 ES02155 delirium delirium non-delirium 38965205 ES02156 delirium post-operative delirium(POD) non-POD 38965205 ES02157 metabolic dysfunction-associated steatotic liver disease (MASLD) MASLD 39048522 ES02158 newborn adiposity 39165088 ES02160 anti-TNF treatment infliximab treatment adalimumab treatment 37551994 ES02161 acute myelocytic leukemia (AML) 39052947 ES02180 acute myelocytic leukemia (AML) 39052947 ES02181 acute myelocytic leukemia (AML) 39052947 ES02182 needs-based family intervention Family therapy Waitlist control 39262181 ES02183 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02184 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02185 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02186 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02187 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02188 electroconvulsive therapy about 1 month after the last ECT session(T1) before the treatment(T0) 39020437 ES02189 monozygotic twinning 39449361 ES02190 epithelial ovarian cancer (EOC) HGSOC benign/borderline 39414761 ES02191 Neonatal Opioid Withdrawal Syndrome (NOWS) NOWS 39238930 ES02192 high-grade cervical intraepithelial neoplasia (CIN2+) 37932662 ES02193 maternal radon exposure Underground 37915496 ES02194 bariatric surgery MetS Responder 6 m after Surgery MetS Responder at Baseline 37834223 ES02195 bariatric surgery MetS Non-Responder 6 m after Surgery MetS Non-Responder at Baseline 37834223 ES02196 asthma Asthma cases Controls 37802634 ES02199 albuterol treatment albuterol healthy controls 37784136 ES02200 LEF treatment responders non-responders 37744384 ES02201 selective fetal growth restriction (sFGR) 37732623 ES02202 infertility anovulatory infertility healthy controls 37715240 ES02203 escitalopram treatment Responders Nonresponders 37701547 ES02204 cognitive intervention response non-response 37664245 ES02205 cognitive intervention 37664245 ES02206 cognitive intervention 37664245 ES02207 adiposity 37652023 ES02208 adiposity 37652023 ES02209 Alzheimer's disease (AD) Alzheimer's disease (AD) cognitively healthy controls (CHCs) 37388929 ES02210 mild cognitive impairment cognitive impairment (MCI) Alzheimer’s disease (AD) 37388929 ES02211 Alzheimer’s Disease cognitive impairment (MCI) cognitively healthy controls (CHCs) 37388929 ES02212 NSAIDs NSAIDs (+) NSAIDs (?) 37341931 ES02213 Hidradenitis suppurativa HS cases controls 37338327 ES02214 Mothers' Adverse Childhood Experiences 37330044 ES02215 hepatocellular carcinoma (HCC) HCC normal 37308980 ES02216 ER negative breast tumors Black women White women 37293596 ES02217 smoking Smokers Non-smokers 37231515 ES02218 smoking Smokers Non-smokers 37231515 ES02219 smoking Smokers Non-smokers 37231515 ES02220 smoking Smokers Non-smokers 37231515 ES02221 smoking Smokers Non-smokers 37231515 ES02222 smoking Smokers Non-smokers 37231515 ES02223 Restless legs syndrome RLS control 37212434 ES02224 Restless legs syndrome RLS controls 37212434 ES02225 Restless legs syndrome RLS controls 37212434 ES02226 Restless legs syndrome RLS controls 37212434 ES02227 monozygotic twinning 37198375 ES02228 weight loss underwent sleeve gastrectomy individuals with <60% excess weight loss individuals with >60% excess weight loss 39724958 ES02229 type 2 diabetes (T2D) individuals with T2D individuals without T2D 39827095 ES02230 adolescent idiopathic scoliosis (AIS) genetically identical monozygotic twins with AIS 39515527 ES02232 treated with assisted reproductive technology full-term placental samples from ART conceived singleton newborns full-term placental samples from naturally conceived singleton newborns 39702541 ES02233 systemic lupus erythematosus remission patients with SLE (disease activity index>3) 3 months later patients with SLE (disease activity index>3) at a flare 39696438 ES02234 systemic lupus erythematosus (SLE) subtypes patients with SLE(disease activity index>3) with different subtypes 39696438 ES02235 fasting plasma glucose plasma fasting glucose levels 39827095 ES02236 frontotemporal lobar degeneration FTLD Controls 37149835 ES02237 blood HbA1c levels blood HbA1c levels 39827095 ES02238 plasma fasting HOMA-IR levels plasma fasting HOMA-IR levels 39827095 ES02239 interaction between T2D and follow-up time individuals with T2D 39827095 ES02240 persistent prediabetes or T2D individuals with persistent prediabetes or T2D 39827095 ES02242 intrauterine insemination (IUI) placentas derived from IUI full term neonates born from uncomplicated pregnancies 39702541 ES02243 intrauterine insemination (IUI) and subfertile (SF) placentas derived from IUI or SF full term neonates born from uncomplicated pregnancies 39702541 ES02244 In vitro culture In vitro culture 39702541 ES02245 inflammatory breast cancer 38971778 ES02246 post-traumatic stress disorder (PTSD) Military Civilian 39072012 ES02247 In vitro fertilization (IVF) In vitro fertilization 39702541 ES02248 intracytoplasmic sperm injection conceived through ICSI conceived spontaneously 39702541 ES02249 fresh embryo transfer (FRESH) fresh embryo transfer 39702541 ES02250 IgG4-related cholangitis individuals with IgG4-related cholangitis healthy controls 39819503 ES02251 primary sclerosing cholangitis - ulcerative colitis (PSC-UC) individuals withprimary sclerosing cholangitis healthy controls 39819503 ES02252 abundance of genus Eggerthella LifeLines-Deep Netherlands Twin Register 39702006 ES02253 prepregnancy BMI pregnant women with obesity (BMI?>?30?kg/m2) pregnant women with obesity (BMI?>?30?kg/m2) 39663190 ES02254 lung cancer risk Not developing LC Developing LC 39624886 ES02255 breast cancer breast cancer benign breast lesion 39605043 ES02256 pulmonary arterial hypertension individual with pulmonary arterial hypertension individual without pulmonary arterial hypertension 38184627 ES02257 maternal educational attainment maternal educational attainment 38052982 ES02258 maternal hyperglycemia maternal hyperglycemia 37386647 ES02259 brain health plasma proteins 35945220 ES02260 depression adults adolescents 35354486